CN104544086B - A health food capable of improving intestinal flora and preparation method thereof - Google Patents
A health food capable of improving intestinal flora and preparation method thereof Download PDFInfo
- Publication number
- CN104544086B CN104544086B CN201510033640.7A CN201510033640A CN104544086B CN 104544086 B CN104544086 B CN 104544086B CN 201510033640 A CN201510033640 A CN 201510033640A CN 104544086 B CN104544086 B CN 104544086B
- Authority
- CN
- China
- Prior art keywords
- parts
- electric field
- health food
- extract
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 87
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 46
- 239000006041 probiotic Substances 0.000 claims abstract description 117
- 235000018291 probiotics Nutrition 0.000 claims abstract description 117
- 230000000529 probiotic effect Effects 0.000 claims abstract description 92
- 239000000843 powder Substances 0.000 claims abstract description 86
- 239000000284 extract Substances 0.000 claims abstract description 82
- 239000000203 mixture Substances 0.000 claims abstract description 53
- 241000233866 Fungi Species 0.000 claims abstract description 43
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 41
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 36
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 36
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 36
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 36
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 36
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 36
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 78
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 66
- 239000000047 product Substances 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 51
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 44
- 230000005684 electric field Effects 0.000 claims description 44
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 44
- 239000001814 pectin Substances 0.000 claims description 44
- 229920001277 pectin Polymers 0.000 claims description 44
- 235000010987 pectin Nutrition 0.000 claims description 44
- 238000000354 decomposition reaction Methods 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 38
- 239000004310 lactic acid Substances 0.000 claims description 33
- 235000014655 lactic acid Nutrition 0.000 claims description 33
- 239000008187 granular material Substances 0.000 claims description 32
- 239000000706 filtrate Substances 0.000 claims description 24
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 23
- 108090000790 Enzymes Proteins 0.000 claims description 23
- 229940088598 enzyme Drugs 0.000 claims description 23
- 239000000905 isomalt Substances 0.000 claims description 23
- 235000010439 isomalt Nutrition 0.000 claims description 23
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 23
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 22
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 22
- 108010046377 Whey Proteins Proteins 0.000 claims description 22
- 102000007544 Whey Proteins Human genes 0.000 claims description 22
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 22
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 22
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 22
- 239000011648 beta-carotene Substances 0.000 claims description 22
- 235000013734 beta-carotene Nutrition 0.000 claims description 22
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 22
- 229960002747 betacarotene Drugs 0.000 claims description 22
- 235000019359 magnesium stearate Nutrition 0.000 claims description 22
- 235000010355 mannitol Nutrition 0.000 claims description 22
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 22
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 22
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 22
- 235000013336 milk Nutrition 0.000 claims description 22
- 239000008267 milk Substances 0.000 claims description 22
- 210000004080 milk Anatomy 0.000 claims description 22
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000005913 Maltodextrin Substances 0.000 claims description 21
- 229920002774 Maltodextrin Polymers 0.000 claims description 21
- 239000012141 concentrate Substances 0.000 claims description 21
- 229940035034 maltodextrin Drugs 0.000 claims description 21
- 239000003826 tablet Substances 0.000 claims description 21
- 235000021119 whey protein Nutrition 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 18
- 108010059820 Polygalacturonase Proteins 0.000 claims description 17
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 17
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- 239000011230 binding agent Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 239000011812 mixed powder Substances 0.000 claims description 14
- 239000002244 precipitate Substances 0.000 claims description 14
- -1 xylooligosaccharides Chemical compound 0.000 claims description 14
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 13
- 239000004365 Protease Substances 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 108010038851 tannase Proteins 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 238000004506 ultrasonic cleaning Methods 0.000 claims description 11
- 241001608472 Bifidobacterium longum Species 0.000 claims description 10
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 10
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 9
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 9
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 9
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 9
- 244000199866 Lactobacillus casei Species 0.000 claims description 9
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 9
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 9
- 230000002255 enzymatic effect Effects 0.000 claims description 9
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 9
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 9
- 229940017800 lactobacillus casei Drugs 0.000 claims description 9
- 239000007779 soft material Substances 0.000 claims description 9
- 239000004382 Amylase Substances 0.000 claims description 8
- 108010065511 Amylases Proteins 0.000 claims description 8
- 102000013142 Amylases Human genes 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 8
- 241000235646 Cyberlindnera jadinii Species 0.000 claims description 8
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 8
- 235000019418 amylase Nutrition 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 8
- 229940106157 cellulase Drugs 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- 229920001202 Inulin Polymers 0.000 claims description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 6
- 229940029339 inulin Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 5
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 5
- 240000000560 Citrus x paradisi Species 0.000 claims description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 5
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 5
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 5
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 5
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 5
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 5
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 5
- 240000000171 Crataegus monogyna Species 0.000 claims description 5
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 5
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 5
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 5
- 235000021536 Sugar beet Nutrition 0.000 claims description 5
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 5
- 235000019895 oat fiber Nutrition 0.000 claims description 5
- 108010004032 Bromelains Proteins 0.000 claims description 4
- 244000194101 Ginkgo biloba Species 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- 240000000588 Hericium erinaceus Species 0.000 claims description 4
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 4
- 239000005909 Kieselgur Substances 0.000 claims description 4
- 108010029541 Laccase Proteins 0.000 claims description 4
- 108090000526 Papain Proteins 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000019835 bromelain Nutrition 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- YERABYSOHUZTPQ-UHFFFAOYSA-P endo-1,4-beta-Xylanase Chemical compound C=1C=CC=CC=1C[N+](CC)(CC)CCCNC(C(C=1)=O)=CC(=O)C=1NCCC[N+](CC)(CC)CC1=CC=CC=C1 YERABYSOHUZTPQ-UHFFFAOYSA-P 0.000 claims description 4
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 235000019419 proteases Nutrition 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 238000009629 microbiological culture Methods 0.000 claims description 3
- 239000005862 Whey Substances 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 39
- 230000036039 immunity Effects 0.000 abstract description 22
- 230000001965 increasing effect Effects 0.000 abstract description 14
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 11
- 230000007661 gastrointestinal function Effects 0.000 abstract description 11
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 7
- 230000002929 anti-fatigue Effects 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000003471 anti-radiation Effects 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 230000001760 anti-analgesic effect Effects 0.000 abstract description 3
- 239000010985 leather Substances 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 43
- 230000000694 effects Effects 0.000 description 41
- 230000009182 swimming Effects 0.000 description 22
- 239000003814 drug Substances 0.000 description 21
- 229940079593 drug Drugs 0.000 description 20
- 238000012360 testing method Methods 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 13
- 230000004151 fermentation Effects 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 241000186000 Bifidobacterium Species 0.000 description 12
- 229920002527 Glycogen Polymers 0.000 description 12
- 229940096919 glycogen Drugs 0.000 description 12
- 241000133134 Saussurea Species 0.000 description 11
- 239000002609 medium Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 230000004071 biological effect Effects 0.000 description 8
- 239000004202 carbamide Substances 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 241000220225 Malus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000003833 bile salt Substances 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 235000012907 honey Nutrition 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000000767 anti-ulcer Effects 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 3
- 208000027244 Dysbiosis Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000003613 bile acid Substances 0.000 description 3
- 229940093761 bile salts Drugs 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 3
- 229940008406 diethyl sulfate Drugs 0.000 description 3
- 230000007140 dysbiosis Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- DANYIYRPLHHOCZ-UHFFFAOYSA-N 5,7-dihydroxy-4'-methoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 DANYIYRPLHHOCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000036649 Dysbacteriosis Diseases 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 206010042566 Superinfection Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 102000011759 adducin Human genes 0.000 description 2
- 108010076723 adducin Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000006538 anaerobic glycolysis Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000005176 gastrointestinal motility Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002522 swelling effect Effects 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- WOLQREOUPKZMEX-BZSNNMDCSA-N (2s)-2-[[(4s)-4-[[(4s)-4-[[4-[(2-amino-4-oxo-1h-pteridin-6-yl)methylamino]benzoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C=C1 WOLQREOUPKZMEX-BZSNNMDCSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010061628 Anal infection Diseases 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 241001480597 Ganoderma tsugae Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 241000143459 Hirsutella Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 239000006154 MacConkey agar Substances 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 241001416980 Paecilomyces hepiali Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009962 acacetin Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 208000017580 chronic wasting disease Diseases 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009654 indole test Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960001595 lincomycin hydrochloride Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000008823 permeabilization Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 229940062013 tamarind extract Drugs 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种可改善肠道菌群的保健食品及其制备方法,从增加益生菌种类和数量、增加益生菌营养物质、抑制有害菌生长及增加人体免疫力等多方面调整肠道菌群,改善胃肠功能。以植物乳杆菌等益生菌粉剂为主要原料,科学复配食用菌提取物、改性膳食纤维;可显著提高人体免疫力、抗炎镇痛、具有抗氧化、抗辐射和抗疲劳等功能的雪莲培养物提取物等,进而在增加肠道益生菌菌群种类的同时,显著增强了内源和外源益生菌在人体肠道内的定植能力及定植时间,有效抑制了肠道有害菌尤其是革兰氏阴性菌的生长及繁殖,充分调节了肠道益生菌菌群的组成,制备出一种益生性强、显著提高人体免疫力、可改善肠道菌群的保健食品。The invention discloses a health food capable of improving intestinal flora and a preparation method thereof, which can adjust intestinal flora from various aspects such as increasing the type and quantity of probiotics, increasing nutrients of probiotics, inhibiting the growth of harmful bacteria, and increasing human immunity. Group, improve gastrointestinal function. Using probiotic powders such as Lactobacillus plantarum as the main raw materials, scientifically compound edible fungus extracts and modified dietary fiber; snow lotus that can significantly improve human immunity, anti-inflammatory and analgesic, and has anti-oxidation, anti-radiation and anti-fatigue functions culture extracts, etc., while increasing the types of intestinal probiotic flora, it significantly enhanced the colonization ability and colonization time of endogenous and exogenous probiotics in the human intestinal tract, and effectively inhibited intestinal harmful bacteria, especially leather. The growth and reproduction of Lambert-negative bacteria fully regulate the composition of intestinal probiotic flora, and prepare a health food with strong probiotic properties, significantly improving human immunity, and improving intestinal flora.
Description
技术领域technical field
本发明涉及保健食品,具体涉及一种可改善肠道菌群的保健食品及其制备方法。The invention relates to health food, in particular to a health food capable of improving intestinal flora and a preparation method thereof.
背景技术Background technique
改善胃肠功能包括通便、调节肠道菌群、促进消化、对胃粘膜损伤有辅助保护四种功能。肠道菌菌相间的平衡受宿主的生理、食物、药物和肠道菌的相互作用等影响,各种因素都会破坏菌相间的平衡,导致肠道从有益菌占优势转向有害菌占优势,从而造成许多肠道疾病。因此,增加肠道有益菌的数量,减少有害菌数量,是保证肠胃健康运转的关键所在。Improving gastrointestinal function includes four functions: defecation, regulation of intestinal flora, promotion of digestion, and auxiliary protection against gastric mucosal damage. The balance of intestinal bacteria is affected by the host's physiology, food, drugs, and the interaction of intestinal bacteria. Cause many intestinal diseases. Therefore, increasing the number of beneficial bacteria in the intestines and reducing the number of harmful bacteria is the key to ensuring the healthy operation of the stomach.
菌群失调(dysbacteriosis)是指机体某部位正常菌群中各菌种间的比例发生较大幅度变化而超出正常范围的状态,由此产生的病症,称为菌群失调症或菌群交替症(microbialselection and substitution)。菌群失调时,多引起二重感染或重叠感染(superinfection),即在原发感染的治疗中,发生了另一种新致病菌的感染。菌群失调的发生多见于使用抗生素和慢性消耗性疾病等。临床上长期大量应用广谱抗生素后,大多数敏感菌和正常菌群被抑制或杀灭,但耐药菌则获得生存优势而大量繁殖致病,如耐药金黄色葡萄球菌引起腹泻、败血症,对抗生素不敏感的白假丝酵母菌引起鹅口疮、阴道炎、肠道和肛门感染。Dysbacteriosis refers to a state in which the proportion of various species in the normal flora of a certain part of the body changes greatly and exceeds the normal range, and the resulting disease is called dysbacteriosis or flora alternation (microbial selection and substitution). When the flora is out of balance, superinfection or superinfection is often caused, that is, another new pathogenic bacteria infection occurs during the treatment of the primary infection. The occurrence of flora imbalance is more common in the use of antibiotics and chronic wasting diseases. After long-term and large-scale application of broad-spectrum antibiotics clinically, most sensitive bacteria and normal flora are inhibited or killed, but drug-resistant bacteria gain a survival advantage and multiply to cause disease. For example, drug-resistant Staphylococcus aureus causes diarrhea, sepsis, Candida albicans, which is not sensitive to antibiotics, causes oral thrush, vaginitis, intestinal and anal infections.
目前,调整肠道菌群的方式主要以补充益生菌种类和数量、补充益生菌所需营养物质(益生因子)、抑制或杀灭肠道有害菌(主要是革兰氏阴性菌)、增强人体免疫力以提高巨噬细胞对有害菌的吞噬作用等方式以达到肠道菌群平衡的目的,中国专利CN 10155908A公开了一种降血脂及调节肠道菌群的益生菌制剂的制备方法,其步骤为(1)将Kefir源植物乳杆菌MA2进行高密度培养,得到发酵液,其菌体密度不小于108cfu/mL;(2)上述发酵液经离心收集获得菌体,加入保护剂,冻干成菌粉;(3)在冻干的菌粉中加入低聚糖混合物,混合均匀即得益生菌制剂成品。该品具有降血脂功能的同时还具有调节肠道菌群的生理功能,可以治疗和预防高血脂症状和调节肠道菌群,且无毒、安全、保存期长,可制成胶囊、微胶囊、冲剂、片剂等。中国专利CN 102511707B公开了一种调节肠道的保健食品及其制作方法,包括以下重量份的组份:天然植物提取物50-60%;低聚果糖8-12%;微生态制剂益生菌2-3%;蜂蜜20-30%;其中,所述天然植物提取物包括无花果提取物、西梅提取物、罗望子提取物、蜜枣提取物,其重量比为10∶1∶1∶1。将天然植物提取物粉碎;称取蜂蜜于蒸发皿中加热至沸,待蜜表面泛起气泡,立即取下;将称量好的天然植物提取物与低聚果糖、益生菌混合,混合的时候要等蜜温度降至30-40℃时再加入,做成面团状的软材;将活好的面团状软材放置,使药料与蜂蜜成分充分混合滋润,制成圆球形丸粒。此产品以纯天然植物提取物、低聚果糖、微生态制剂为主要原料,在不刺激肠道的前提下调节肠道功能,达到预防治疗便秘的效果。中国专利CN 103054938A公开了一种调节胃肠菌群失调的口服制剂,它涉及一种口服制剂。本发明要解决现在临床上长期大量应用广谱抗生素调节胃肠菌群失调,产生耐药性的问题。本发明的口服制剂是由菊粉、人参提取物、白术提取物、茯苓提取物、甘草提取物制成。本发明一种有助于改善胃肠功能的口服制剂组方科学、原料易得、配制方便、作用明显,副作用小,且适合于工业化生产。At present, the ways to adjust the intestinal flora are mainly to supplement the types and quantities of probiotics, to supplement the nutrients (prebiotic factors) required by probiotics, to inhibit or kill harmful intestinal bacteria (mainly Gram-negative bacteria), and to strengthen the human body. Immunity is to improve the phagocytosis of harmful bacteria by macrophages to achieve the purpose of intestinal flora balance. Chinese patent CN 10155908A discloses a preparation method of a probiotic preparation for reducing blood fat and regulating intestinal flora. The steps are (1) high-density culture of Kefir-derived Lactobacillus plantarum MA2 to obtain a fermentation broth whose cell density is not less than 10 8 cfu/mL; (2) the above-mentioned fermentation broth is collected by centrifugation to obtain the cells, and a protective agent is added, Freeze-dried into bacterial powder; (3) Add oligosaccharide mixture to the freeze-dried bacterial powder and mix evenly to obtain the finished probiotic preparation. This product not only has the function of lowering blood fat, but also has the physiological function of regulating intestinal flora. It can treat and prevent symptoms of hyperlipidemia and regulate intestinal flora. It is non-toxic, safe, and has a long shelf life. It can be made into capsules and microcapsules. , granules, tablets, etc. Chinese patent CN 102511707B discloses a health food for regulating intestinal tract and its preparation method, including the following components in parts by weight: natural plant extract 50-60%; fructooligosaccharide 8-12%; probiotics 2 -3%; 20-30% honey; wherein, the natural plant extracts include fig extract, prune extract, tamarind extract, candied date extract, and the weight ratio is 10:1:1:1. Crush the natural plant extracts; weigh the honey and heat it to boiling in an evaporating dish, and take it off immediately when bubbles appear on the surface of the honey; mix the weighed natural plant extracts with fructooligosaccharides and probiotics. Wait until the temperature of the honey drops to 30-40°C before adding it to make a dough-like soft material; place the live dough-like soft material so that the medicinal material and honey ingredients are fully mixed and moistened to make spherical pellets. This product uses pure natural plant extracts, fructooligosaccharides, and probiotics as the main raw materials to regulate intestinal function without stimulating the intestinal tract and achieve the effect of preventing and treating constipation. Chinese patent CN 103054938A discloses an oral preparation for regulating gastrointestinal flora imbalance, which relates to an oral preparation. The present invention solves the problem of long-term and large-scale clinical application of broad-spectrum antibiotics to regulate gastrointestinal flora imbalance and produce drug resistance. The oral preparation of the present invention is made from inulin, ginseng extract, Atractylodes macrocephala extract, poria cocos extract and licorice extract. The oral preparation for improving gastrointestinal function of the invention has scientific formula, easy-to-obtain raw materials, convenient preparation, obvious effects, little side effects and is suitable for industrialized production.
上述公开的专利采用为传统的益生菌和益生因子及其组合,没有分离或培养出益生性更强的益生菌,其益生菌生物活性还不是很理想,传统的益生因子对益生菌的增殖作用滞后,并且在抑制肠道有害菌、增强人体免疫力进而提高巨噬细胞对有害菌的吞噬作用,以改善肠道益生菌群方面研究的较少。The above-mentioned published patents use traditional probiotics, prebiotic factors and their combination, no probiotics with stronger probiotic properties have been isolated or cultivated, and the biological activity of probiotics is not very satisfactory. lag behind, and less research has been done on the improvement of intestinal probiotics by inhibiting harmful intestinal bacteria, enhancing human immunity and improving the phagocytosis of harmful bacteria by macrophages.
发明内容Contents of the invention
本发明所解决的技术问题是克服现有改善胃肠功能保健品的缺陷,从增加益生菌种类和数量、增加益生菌营养物质、抑制有害菌生长及增加人体免疫力等多方面调整肠道菌群,改善胃肠功能。以植物乳杆菌等益生菌粉剂为主要原料,科学复配可修复细胞组织、具有抗溃疡作用、抗氧化作用、清除自由基作用和抗衰老作用,可显著提升人体整体免疫力和增强体力、改善胃肠功能的食用菌提取物;含有高含量可溶性纤维素的改性膳食纤维;可显著提高人体免疫力、抗炎镇痛、具有抗氧化、抗辐射和抗疲劳等功能的雪莲培养物提取物等为原料,进而在增加肠道益生菌菌群种类的同时,显著增强了内源和外源益生菌在人体肠道内的定植能力及定植时间,有效抑制了肠道有害菌尤其是革兰氏阴性菌的生长及繁殖,充分调节了肠道益生菌菌群的组成,制备出一种益生性强、显著提高人体免疫力、可改善肠道菌群的保健食品。The technical problem solved by the present invention is to overcome the defects of the existing health care products for improving gastrointestinal function, and adjust the intestinal bacteria from various aspects such as increasing the types and quantities of probiotics, increasing the nutrients of probiotics, inhibiting the growth of harmful bacteria, and increasing human immunity. Group, improve gastrointestinal function. Using probiotic powder such as Lactobacillus plantarum as the main raw material, scientific compound can repair cell tissue, have anti-ulcer effect, anti-oxidation effect, free radical scavenging effect and anti-aging effect, which can significantly improve the overall immunity of the human body and enhance physical strength, improve Edible fungus extract with gastrointestinal function; modified dietary fiber containing high content of soluble cellulose; Saussurea officinalis culture extract that can significantly improve human immunity, anti-inflammatory and analgesic, and has anti-oxidation, anti-radiation and anti-fatigue functions etc. as raw materials, while increasing the types of intestinal probiotic flora, it significantly enhanced the colonization ability and colonization time of endogenous and exogenous probiotics in the human intestinal tract, and effectively inhibited intestinal harmful bacteria, especially Gram The growth and reproduction of negative bacteria can fully regulate the composition of intestinal probiotic flora, and prepare a health food with strong probiotic properties, significantly improve human immunity, and improve intestinal flora.
为了达到上述目的,本发明采用以下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
一种可改善肠道菌群的保健食品,由以下重量份数的原料制备:A health food capable of improving intestinal flora, prepared from the following raw materials in parts by weight:
D-甘露糖醇5-50份,麦芽糊精5-30份,微晶纤维素5-30份,益生菌粉剂5-30份,改性膳食纤维5-20份,低聚木糖3-15份,异麦芽酮糖醇3-15份,浓缩乳清蛋白3-15份,食用菌提取物2-12份,雪莲培养物提取物3-10份,果胶分解物2-10份,α-环状糊精1-10份,柠檬酸0.1-3份,硬脂酸镁0.1-3份,牛奶香精0.1-3份,β-胡萝卜素0.01-3份;5-50 parts of D-mannitol, 5-30 parts of maltodextrin, 5-30 parts of microcrystalline cellulose, 5-30 parts of probiotic powder, 5-20 parts of modified dietary fiber, 3- 15 parts, 3-15 parts of isomalt, 3-15 parts of concentrated whey protein, 2-12 parts of edible fungus extract, 3-10 parts of snow lotus culture extract, 2-10 parts of pectin decomposition product, 1-10 parts of α-cyclodextrin, 0.1-3 parts of citric acid, 0.1-3 parts of magnesium stearate, 0.1-3 parts of milk essence, 0.01-3 parts of β-carotene;
优选地,所述可改善肠道菌群的保健食品,由以下重量份数的原料制备:Preferably, the health food that can improve intestinal flora is prepared from the following raw materials in parts by weight:
D-甘露糖醇15-35份,麦芽糊精10-20份,微晶纤维素10-20份,益生菌粉剂10-20份,改性膳食纤维8-12份,低聚木糖7-11份,异麦芽酮糖醇7-11份,浓缩乳清蛋白7-11份,食用菌提取物5-10份,雪莲培养物提取物5-8份,果胶分解物5-7份,α-环状糊精1.5-5份,柠檬酸1.5-2.5份,硬脂酸镁1.5-2.5份,牛奶香精1.5-2.5份,β-胡萝卜素1-2份;15-35 parts of D-mannitol, 10-20 parts of maltodextrin, 10-20 parts of microcrystalline cellulose, 10-20 parts of probiotic powder, 8-12 parts of modified dietary fiber, 7- 11 parts, 7-11 parts of isomalt, 7-11 parts of concentrated whey protein, 5-10 parts of edible fungus extract, 5-8 parts of snow lotus culture extract, 5-7 parts of pectin decomposition product, 1.5-5 parts of α-cyclodextrin, 1.5-2.5 parts of citric acid, 1.5-2.5 parts of magnesium stearate, 1.5-2.5 parts of milk essence, 1-2 parts of β-carotene;
更优选地,所述可改善肠道菌群的保健食品,由以下重量份数的原料制备:More preferably, the health food that can improve intestinal flora is prepared from the following raw materials in parts by weight:
D-甘露糖醇25份,麦芽糊精15份,微晶纤维素15份,益生菌粉剂15份,改性膳食纤维10份,低聚木糖9份,异麦芽酮糖醇9份,浓缩乳清蛋白9份,食用菌提取物8份,雪莲培养物提取物7份,果胶分解物6份,α-环状糊精3份,柠檬酸2份,硬脂酸镁2份,牛奶香精2份,β-胡萝卜素1.5份;25 parts of D-mannitol, 15 parts of maltodextrin, 15 parts of microcrystalline cellulose, 15 parts of probiotic powder, 10 parts of modified dietary fiber, 9 parts of xylooligosaccharide, 9 parts of isomalt, concentrated 9 parts of whey protein, 8 parts of edible mushroom extract, 7 parts of snow lotus culture extract, 6 parts of pectin decomposition product, 3 parts of α-cyclodextrin, 2 parts of citric acid, 2 parts of magnesium stearate, milk 2 parts of essence, 1.5 parts of β-carotene;
进一步地,所述益生菌粉剂包括但不限于以下益生菌粉剂中的一种或多种:例如:植物乳杆菌(Lactobacillus plantarum)、两岐双岐杆菌(Bifidobacterium bifidum)、婴儿双岐杆菌(B.infantis)、长双岐杆菌(B.longum)、短双岐杆菌(B.breve)、青春双岐杆菌(B.adolescentis)、保加利亚乳杆菌(Lactobacillus.Bulgaricus)、嗜酸乳杆菌(L.acidophilus)、干酪乳杆菌(Lactobacillus Casey)、嗜热链球菌(Streptococcusthermophilus);也包括用于保健食品的真菌粉剂中的一种或多种,例如:酿酒酵母(Saccharomyces cerevisiae)、产朊假丝酵母(Cadida atilis)、乳酸克鲁维酵母(Kluyveromyces lactis)、卡氏酵母(Saccharomyces carlsbergensis)、蝙蝠蛾拟青霉(Paecilomyces hepiali Chen et Dai,sp.nov)、蝙蝠蛾被毛孢(Hirsutella hepiali Chenet Shen)、灵芝(Ganoderma lucidum)、紫芝(Ganoderma sinensis)、松杉灵芝(Ganodermatsugae)、红曲霉(Monacus anka)、紫红曲霉(Monacus purpureus);Further, the probiotic powder includes, but is not limited to, one or more of the following probiotic powders: for example: Lactobacillus plantarum, Bifidobacterium bifidum, Bifidobacterium infantis (B infantis), Bifidobacterium longum (B.longum), Bifidobacterium breve (B.breve), Bifidobacterium adolescentis (B.adolescentis), Lactobacillus bulgaricus (Lactobacillus.Bulgaricus), Lactobacillus acidophilus (L. acidophilus), Lactobacillus casei (Lactobacillus Casey), Streptococcus thermophilus (Streptococcus thermophilus); also include one or more of fungal powders used in health food, such as: Saccharomyces cerevisiae, Candida utilis (Cadida atilis), Kluyveromyces lactis, Saccharomyces carlsbergensis, Paecilomyces hepiali Chen et Dai, sp.nov, Hirsutella hepiali Chenet Shen ), Ganoderma lucidum, Ganoderma sinensis, Ganodermatsugae, Monacus anka, Monacus purpureus;
所述益生菌粉剂益生菌活菌含量为:7x1012-9x1012cfu/g;The probiotic live bacteria content of the probiotic powder is: 7x10 12 -9x10 12 cfu/g;
优选地,所述益生菌粉剂由以下重量份数的粉剂均匀混合而成:植物乳杆菌40-50份,长双歧杆菌30-45份,两岐双岐杆菌25-35份,青春双岐杆菌15-20份,保加利亚乳杆菌15-20份,嗜酸乳杆菌10-15份,干酪乳杆菌8-10份,嗜热链球菌8-10份,酿酒酵母8-10份,产朊假丝酵母菌4-6份;Preferably, the probiotic powder is uniformly mixed with the following powders in parts by weight: 40-50 parts of Lactobacillus plantarum, 30-45 parts of Bifidobacterium longum, 25-35 parts of Bifidobacterium bifidum, and Bifidobacterium adolescent Bacillus 15-20 parts, Lactobacillus bulgaricus 15-20 parts, Lactobacillus acidophilus 10-15 parts, Lactobacillus casei 8-10 parts, Streptococcus thermophilus 8-10 parts, Saccharomyces cerevisiae 8-10 parts 4-6 parts of Trichosomyces;
优选地,所述植物乳杆菌粉剂是由植物乳杆菌(Lactobacillus plantarum)tlj-2014制备,该菌株已于2014年7月2日保藏于中国微生物菌种保藏管理委员会普通微生物中心(简称CGMCC,地址为:北京市朝阳区北辰西路1号院3号.中国科学院微生物研究所.邮编:100101),保藏编号为CGMCC NO.9405,分类命名为:植物乳杆菌Lactobacillus plantarum。Preferably, the Lactobacillus plantarum powder is prepared by Lactobacillus plantarum (Lactobacillus plantarum) tlj-2014, which has been preserved in the General Microorganism Center of China Committee for Culture Collection of Microorganisms (CGMCC for short, address It is: No. 3, No. 1, Beichen West Road, Chaoyang District, Beijing. Institute of Microbiology, Chinese Academy of Sciences. Zip code: 100101), the preservation number is CGMCC NO.9405, and the classification name is Lactobacillus plantarum.
进一步地,所述改性膳食纤维是将膳食纤维经物理、化学或生物的方法处理而得到的,可溶性纤维素含量高、生物活性强、对肠道益生菌群有重要的、积极作用的纤维素,与普通膳食纤维相比,其生物活性作用更强大:1)可溶性纤维素含量高,更容易被益生菌利用,可提高益生菌在肠道的生长及繁殖能力,增加益生菌菌群的种类和数量,降低大肠pH值,改善肠道微生态环境;2)强大的吸附能力,经改性后,纤维素的比表面积增大,网格结构丰富,吸附力增强,螯合、吸附胆固醇和胆汁酸类的有机分子能力更强、抑制人体对它们的吸收;3)离子交换能力增强,对金属元素,特别是重金属元素吸附效果更强;4)持水性、膨胀性、增稠性更强且不受酸、碱、盐的影响,5)调节和维持肠道菌群的定植时间,增强肠道的消化和吸收能力,提高人体免疫力;6)促进胃肠蠕动,减缓并消除胃胀、腹胀等不良反应;7)包埋作用强,防止外界环境(氧气、温度、光照、湿度等)因素对产品品质的影响,稳定了产品的生物活性,延长了产品的保质期;Further, the modified dietary fiber is obtained by processing the dietary fiber through physical, chemical or biological methods, and is a fiber with high content of soluble cellulose, strong biological activity, and important and positive effects on intestinal probiotics Compared with ordinary dietary fiber, its biological activity is stronger: 1) The content of soluble cellulose is high, and it is easier to be used by probiotics, which can improve the growth and reproduction ability of probiotics in the intestinal tract, and increase the concentration of probiotics. 2) Strong adsorption capacity, after modification, the specific surface area of cellulose increases, the grid structure is rich, the adsorption force is enhanced, and cholesterol is chelated and adsorbed The organic molecules of bile acids and bile acids have stronger ability to inhibit the absorption of them by the human body; 3) The ion exchange capacity is enhanced, and the adsorption effect on metal elements, especially heavy metal elements is stronger; 4) The water holding capacity, swelling property and thickening property are better Strong and not affected by acid, alkali, and salt, 5) regulate and maintain the colonization time of intestinal flora, enhance the digestion and absorption capacity of the intestinal tract, and improve human immunity; 6) promote gastrointestinal motility, slow down and eliminate gastric 7) strong embedding effect, preventing external environmental factors (oxygen, temperature, light, humidity, etc.) from affecting product quality, stabilizing the biological activity of the product, and prolonging the shelf life of the product;
优选地,所述改性纤维是由菊粉、苹果纤维、燕麦纤维、小麦纤维中的一种或多种经生物酶酶解而得到的;Preferably, the modified fiber is obtained by enzymatic hydrolysis of one or more of inulin, apple fiber, oat fiber and wheat fiber;
更优选地,所述改性膳食纤维的制备方法包括以下步骤:将菊粉、苹果纤维、燕麦纤维、小麦纤维按质量比8-10:4-6:3-5:2-4均匀混合,加入其质量3-7倍的水,室温200-300W、35-40KHz条件超声提取10-15min,然后在电场强度20-40kV/cm,脉冲时间400-500μs,脉冲频率200-300Hz条件下进行高压脉冲电场提取;用乳酸调节pH值为4.5-6.5,加入混合物质量0.1-0.3%的生物酶,于45-55℃酶解20-48min;酶解液减压浓缩、冷冻干燥、低温粉碎至粒径为0.1-0.3mm即得改性膳食纤维;More preferably, the preparation method of the modified dietary fiber comprises the following steps: uniformly mixing inulin, apple fiber, oat fiber, and wheat fiber in a mass ratio of 8-10:4-6:3-5:2-4, Add water 3-7 times its mass, ultrasonically extract at room temperature 200-300W, 35-40KHz for 10-15min, and then perform high-voltage under the conditions of electric field strength 20-40kV/cm, pulse time 400-500μs, pulse frequency 200-300Hz Pulse electric field extraction; use lactic acid to adjust the pH value to 4.5-6.5, add 0.1-0.3% of the mass of the mixture of biological enzymes, and enzymolyze at 45-55°C for 20-48min; Modified dietary fiber with a diameter of 0.1-0.3mm;
所述生物酶为木聚糖酶、纤维素酶、漆酶、果胶酶、单宁酶按质量比5-9:2-4:2-4:2-4:1-3均匀混合。The biological enzymes are xylanase, cellulase, laccase, pectinase and tannase, which are uniformly mixed in a mass ratio of 5-9:2-4:2-4:2-4:1-3.
进一步地,所述食用菌提取物是以修复细胞组织、具有抗溃疡作用、抗氧化作用、清除自由基作用和抗衰老作用,可显著提升人体整体疫免力和增强体力、改善胃肠功能的食用菌经超声清洗、高压脉冲电场处理和生物酶解而制备的;Further, the edible fungus extract is based on repairing cell tissue, having anti-ulcer effect, anti-oxidation effect, free radical scavenging effect and anti-aging effect, which can significantly improve the overall immunity of the human body, enhance physical strength, and improve gastrointestinal function. Edible mushrooms are prepared by ultrasonic cleaning, high-voltage pulse electric field treatment and biological enzymolysis;
优选地,所述食用菌提取物的制备方法包括如下步骤:将猴头菇、银杏和黑木耳分别放入装有0.3-0.5%碳酸氢钠溶液的超声波清洗机中于200W、40KHz清洗5-10min,沥干,切分成相等规格,长、宽为5-10mm,厚度3-5mm的片或丁,按质量比按质量比8-10:5-7:4-6均匀混合,然后于-21—-25℃冷冻10-30min,立即进行粉碎,粉碎物粒径为0.2-1mm;加入粉碎物质量3-5倍的水得混合物,调整混合物pH为4.5-6,室温下在电场强度35-45kV/cm,脉冲时间500-700μs,脉冲频率200-400Hz条件下进行高压脉冲电场处理,升温至45~55℃,加入混合物重量0.5-1.2%的混合酶酶解4~6小时,得到食用菌酶解液,减压浓缩至固形物含量为30%以上,冷冻干燥、低温粉碎至粒径为0.1-0.3mm即得食用菌提取物;Preferably, the preparation method of the edible fungus extract comprises the steps of: putting Hericium erinaceus, ginkgo biloba and black fungus into an ultrasonic cleaning machine equipped with 0.3-0.5% sodium bicarbonate solution and cleaning them at 200W, 40KHz for 5- 10min, drain, cut into pieces or cubes of equal specifications, length and width 5-10mm, thickness 3-5mm, mix evenly according to the mass ratio of 8-10:5-7:4-6, and then in- Freeze at 21—-25°C for 10-30 minutes, and crush immediately. The particle size of the crushed product is 0.2-1mm; -45kV/cm, pulse time 500-700μs, pulse frequency 200-400Hz, conduct high-voltage pulse electric field treatment, heat up to 45-55°C, add 0.5-1.2% of the weight of the mixture to enzymolyze for 4-6 hours, and get edible Bacteria enzymolysis solution, concentrated under reduced pressure until the solid content is more than 30%, freeze-dried, and crushed at low temperature until the particle size is 0.1-0.3mm to obtain the edible fungus extract;
所述食用菌酶解液中食用菌多糖含量高达6.82%;The edible fungus polysaccharide content in the edible fungi enzymatic solution is as high as 6.82%;
所述混合酶重量份数组成为:木瓜蛋白酶20-30份,菠萝蛋白酶20-30份,葡聚糖酶10-15份,木聚糖酶10-15份,戊聚糖酶10-15份,无花果蛋白酶5-10份,中温淀粉酶5-10份,果胶酶5-10份,单宁酶3-5份。The number of parts by weight of the mixed enzyme is: 20-30 parts of papain, 20-30 parts of bromelain, 10-15 parts of dextranase, 10-15 parts of xylanase, 10-15 parts of pentosanase, 5-10 parts of ficinase, 5-10 parts of mid-temperature amylase, 5-10 parts of pectinase, and 3-5 parts of tannase.
进一步地,所述雪莲培养物购自大连普瑞康生物技术有限公司,为紫红色团块状颗粒,种源系“天山雪莲”;Further, the culture of Saussurea volata was purchased from Dalian Puruikang Biotechnology Co., Ltd., which is purple-red agglomerated particles, and its provenance is "Tianshan Saussurea chinensis";
进一步地,所述雪莲培养物提取物是以雪莲培养物为原料经冷冻、粉碎、微波辅助超声提取、低温酶解、高压脉冲电场提取等低温提取技术而制得,可最大限度地保留金合欢素、粗毛豚草素、芦丁、槲皮素等黄酮类物质和其它抗氧化、易挥发、热敏性有效成分;Further, the Saussurea volata culture extract is prepared by low-temperature extraction techniques such as freezing, crushing, microwave-assisted ultrasonic extraction, low-temperature enzymolysis, high-voltage pulse electric field extraction, etc., using the Saussurea chinensis culture as raw material, which can retain the Acacia acacia to the greatest extent. flavonoids such as ragragulinin, ragragpinin, rutin, quercetin, and other antioxidant, volatile, and heat-sensitive active ingredients;
优选地,所述雪莲培养物提取物的制备方法包括如下步骤:取雪莲培养物,浸入盛有质量百分比浓度为0.9-1.1%的无菌低聚果糖水溶液的容器中,取出,然后于-18—-23℃冷冻5-10min;立即粉碎至粒径0.3-1mm;置容器中并添加3-5倍重量的水或35-75%的乙醇,得混合物料,用乳酸调节pH值为3.5-5.5,于室温下在电场强度25-35kV/cm,脉冲时间300-500μs,脉冲频率200-300Hz条件下进行高压脉冲电场处理;然后升温至30-40℃,保温,在功率150-300W、频率2000Hz条件下进行微波提取,其中,每次微波辐照总时间60-80s,进行间隔式辐照:辐照10s,间隔10s,如此辐照10次,同时在功率200-300W,频率30-40KHz条件下进行超声波辅助提取;继续升温至40-50℃,保温,然后加入混合物料总重量2.5-4%的复配酶酶解30-50min,过滤,得滤液;滤渣用1-3倍重量76-80℃水漂洗3次,漂洗液与滤液合并,均匀混合,于室温下在电场强度35-45kV/cm,脉冲时间400-600μs,脉冲频率200-300Hz条件下进行高压脉冲电场处理即得雪莲培养物提取物;Preferably, the preparation method of the Saussurea edulis culture extract comprises the following steps: taking the Saussurea edulis culture, immersing it in a container filled with a sterile fructooligosaccharide aqueous solution with a mass percent concentration of 0.9-1.1%, taking it out, and then storing it at -18 ——Freeze at 23°C for 5-10 minutes; crush immediately to a particle size of 0.3-1mm; put in a container and add 3-5 times the weight of water or 35-75% ethanol to obtain a mixed material, and use lactic acid to adjust the pH value to 3.5- 5.5. Perform high-voltage pulse electric field treatment at room temperature under the conditions of electric field strength 25-35kV/cm, pulse time 300-500μs, pulse frequency 200-300Hz; Microwave extraction is carried out under the condition of 2000Hz, wherein, the total time of each microwave irradiation is 60-80s, and interval irradiation is carried out: irradiation for 10s, interval of 10s, such irradiation 10 times, at the same time, the power is 200-300W, the frequency is 30-40KHz Ultrasonic-assisted extraction is carried out under the conditions; continue to heat up to 40-50°C, keep warm, then add a compound enzyme with a total weight of 2.5-4% of the mixed material to enzymolyze for 30-50min, filter to obtain a filtrate; filter residue with 1-3 times the weight of 76 Rinse with water at -80°C for 3 times, combine the rinsing liquid and the filtrate, mix evenly, and conduct high-voltage pulse electric field treatment at room temperature under the conditions of electric field strength 35-45kV/cm, pulse time 400-600μs, and pulse frequency 200-300Hz to obtain snow lotus culture extract;
所述复配酶由果胶酶、纤维素酶、单宁酶、淀粉酶和蛋白酶按质量比3-7:3-5:2-4:1-3:1-2均匀混合。The compound enzyme is uniformly mixed with pectinase, cellulase, tannase, amylase and protease in a mass ratio of 3-7:3-5:2-4:1-3:1-2.
所述果胶分解物具有天然、柔和适口的酸味和显著的抑菌特性,尤其对大肠杆菌抑制作用最强,同时还具有较强的抗氧化性,浓度达到0.01%时即可作用,对超氧自由基、羟自由基和DPPH自由基都表现出很强的消除作用,当浓度达到1.0%时,消除效果达到100%;The pectin decomposition product has a natural, soft and palatable sour taste and significant antibacterial properties, especially the strongest inhibitory effect on Escherichia coli, and also has strong antioxidant properties. It can act when the concentration reaches 0.01%. Oxygen free radicals, hydroxyl free radicals and DPPH free radicals all showed a strong elimination effect, and when the concentration reached 1.0%, the elimination effect reached 100%;
所述果胶分解物的科学复配,可有效提高本发明保健食品的适口性,最主要的是其显著的抑菌特性和抗氧化性避免了有效成分的氧化和微生物侵害,稳定和提高了产品的生物活性,延长了产品的保质期;The scientific compounding of the decomposed pectin can effectively improve the palatability of the health food of the present invention. The most important thing is that its remarkable antibacterial properties and anti-oxidation properties avoid the oxidation of active ingredients and microbial damage, and stabilize and improve the The biological activity of the product prolongs the shelf life of the product;
进一步地,所述果胶分解物是以柠檬、橙、柚、柑桔、葡萄等果皮或山楂、甜菜、苹果等废渣经超声清洗、高压脉冲提取、热水浸提、醇沉获得果胶,然后经果胶酶酶解而制得的;优选地,所述果胶分解物的制备方法,包括如下步骤:将新鲜的山楂果渣、柚皮、苹果渣、甜菜渣分别放入装有1.2%碳酸氢钠溶液的超声波清洗机中于200W、40KHz清洗5-10min,沥干,切分成相等规格,长、宽为5-10mm,厚度3-5mm的片或丁,按质量比8-12:3-5:2-4:2-4均匀混合,然后于-21—-25℃冷冻10-30min;立即进行粉碎,粉碎物粒径为0.1-1mm;加入粉碎物质量3-5倍的去离子水,混合均匀,用柠檬酸调节pH值为2-3,室温下在电场强度35-45kV/cm,脉冲时间500-700μs,脉冲频率200-400Hz条件下进行高压脉冲电场处理,接着常压煮沸30-50min,布袋过滤,滤渣用其质量1-3倍的滤液常压煮沸40-60min,布袋过滤,合并滤液,硅藻土过滤,使滤液澄清,在75℃下减压浓缩至固形物含量为6-10%,迅速冷却至室温,加入浓缩液1.5倍体积的pH值为2-3的95%乙醇,静置20-30min,使果胶沉淀出来,4000r/min离心5-10min,回收沉淀,用2倍体积的无水乙醇洗脱,离心,回收沉淀,如此操作2次,得到的沉淀于40-60℃真空干燥2-3h,获得果胶,加入果胶质量4-5倍的40-50℃水,搅拌,均匀混合,保温,用乳酸调节pH值为4.5-5.5,加入0.3-0.8U/mL的果胶酶酶解2-4h,酶解液过滤,滤液于沸水中灭酶10-15min,冷却至室温,超滤浓缩、冷冻干燥即得果胶分解物。Further, the decomposed pectin is obtained from peels of lemons, oranges, pomelo, oranges, grapes, etc., or waste residues such as hawthorn, sugar beets, apples, etc., through ultrasonic cleaning, high-pressure pulse extraction, hot water extraction, and alcohol precipitation. Then it is obtained through pectinase enzymolysis; preferably, the preparation method of the pectin decomposition product comprises the following steps: putting fresh hawthorn pomace, pomelo peel, apple pomace, and sugar beet pomace into a container containing 1.2 Wash in an ultrasonic cleaning machine with % sodium bicarbonate solution at 200W, 40KHz for 5-10min, drain, cut into pieces or dices of equal specifications, 5-10mm in length and width, and 3-5mm in thickness, according to the mass ratio of 8-12 :3-5:2-4:2-4 Mix evenly, then freeze at -21—-25°C for 10-30min; grind immediately, the particle size of the grind is 0.1-1mm; add 3-5 times the amount of grind Deionized water, mix evenly, adjust the pH value to 2-3 with citric acid, carry out high-voltage pulse electric field treatment under the conditions of electric field strength 35-45kV/cm, pulse time 500-700μs, pulse frequency 200-400Hz at room temperature, and then normal Boil under pressure for 30-50 minutes, filter with a cloth bag, boil the filter residue with 1-3 times the filtrate at normal pressure for 40-60 minutes, filter with a cloth bag, combine the filtrates, filter with diatomaceous earth to clarify the filtrate, and concentrate under reduced pressure at 75°C to solid The pectin content is 6-10%, quickly cooled to room temperature, add 95% ethanol with a pH value of 2-3 of 1.5 times the volume of the concentrated solution, let it stand for 20-30min to precipitate the pectin, and centrifuge at 4000r/min for 5-10min , recover the precipitate, elute with 2 times the volume of absolute ethanol, centrifuge, recover the precipitate, and do this twice. The obtained precipitate is vacuum-dried at 40-60°C for 2-3 hours to obtain pectin, and add pectin quality 4-5 times 40-50℃ water, stir, mix evenly, keep warm, adjust the pH value to 4.5-5.5 with lactic acid, add 0.3-0.8U/mL pectinase for 2-4h, filter the enzymatic solution, and put the filtrate in boiling water Inactivate the enzyme for 10-15 minutes, cool to room temperature, concentrate by ultrafiltration, and freeze-dry to obtain the pectin decomposition product.
本发明保健食品的剂型为口服制剂,可以为片剂、粉剂、胶囊剂或颗粒剂,优选为片剂。The dosage form of the health food of the present invention is oral preparation, which can be tablet, powder, capsule or granule, preferably tablet.
所述片剂服用、运输、贮存及携带方便,性状稳定,剂量准确,成本低。The tablet is convenient to take, transport, store and carry, has stable properties, accurate dosage and low cost.
本发明可改善肠道菌群的保健食品片剂、胶囊剂或颗粒剂可以通过如下方法制备,包括如下步骤:The health food tablet, capsule or granule capable of improving intestinal flora of the present invention can be prepared by the following method, including the following steps:
1)按照配方比例,分别取D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、牛奶香精粉碎,过60-120目筛,然后混合3-15min,得混合粉;1) Take D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharides, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, The milk essence is crushed, passed through a 60-120 mesh sieve, and then mixed for 3-15 minutes to obtain a mixed powder;
2)将果胶分解物、柠檬酸、β-胡萝卜素溶于水中制成13-18%的水溶液,作为粘合剂;2) dissolving pectin decomposition products, citric acid, and β-carotene in water to make a 13-18% aqueous solution as a binder;
3)向所述混合粉中加入所述粘合剂制成软材,用10-20目筛制粒,得湿颗粒,置微波干燥机中于功率3000W、频率2450MHz、温度55-65℃干燥3-8min,用10-20目筛快速整粒;3) Add the binder to the mixed powder to make a soft material, granulate with a 10-20 mesh sieve to obtain wet granules, and dry them in a microwave dryer with a power of 3000W, a frequency of 2450MHz, and a temperature of 55-65°C 3-8min, use a 10-20 mesh sieve to quickly granulate;
4)将改性膳食纤维、α-环状糊精和益生菌粉混合5-10min,得包埋益生菌粉剂;4) Mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 5-10 minutes to obtain embedded probiotic powder;
5)整好的颗粒与包埋益生菌粉剂、硬脂酸镁混合5-10min,混合均匀后,制成片剂、胶囊剂或颗粒剂。5) The prepared granules are mixed with embedded probiotic powder and magnesium stearate for 5-10 minutes, and after mixing evenly, they are made into tablets, capsules or granules.
优选地,本发明保健食品片剂的制备方法,包括如下步骤:Preferably, the preparation method of health food tablet of the present invention, comprises the steps:
1)按照配方比例,分别取D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、牛奶香精粉碎,过60-120目筛,然后混合3-15min,得混合粉;1) Take D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharides, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, The milk essence is crushed, passed through a 60-120 mesh sieve, and then mixed for 3-15 minutes to obtain a mixed powder;
2)将果胶分解物、柠檬酸、β-胡萝卜素溶于水中制成13-18%的水溶液,作为粘合剂;2) dissolving pectin decomposition products, citric acid, and β-carotene in water to make a 13-18% aqueous solution as a binder;
3)向所述混合粉中加入所述粘合剂制成软材,用10-20目筛制粒,得湿颗粒,置微波干燥机中于功率3000W、频率2450MHz、温度55-65℃干燥3-8min,用10-20目筛快速整粒;3) Add the binder to the mixed powder to make a soft material, granulate with a 10-20 mesh sieve to obtain wet granules, and dry them in a microwave dryer with a power of 3000W, a frequency of 2450MHz, and a temperature of 55-65°C 3-8min, use a 10-20 mesh sieve to quickly granulate;
4)将改性膳食纤维、α-环状糊精和益生菌粉混合5-10min,得包埋益生菌粉剂;4) Mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 5-10 minutes to obtain embedded probiotic powder;
5)整好的颗粒与包埋益生菌粉剂、硬脂酸镁混合5-10min,混合均匀后,压片、包装即得保健食品片剂。5) The prepared granules are mixed with the embedded probiotic powder and magnesium stearate for 5-10 minutes, and after mixing evenly, they are pressed into tablets and packaged to obtain health food tablets.
本发明可改善肠道菌群的保健食品粉剂的制备方法,包括如下步骤:The preparation method of the health food powder capable of improving the intestinal flora of the present invention comprises the following steps:
1)按配方比例,将改性膳食纤维、α-环状糊精和益生菌粉混合5-10min,得包埋益生菌粉剂;1) According to the formula ratio, mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 5-10 minutes to obtain the embedded probiotic powder;
2)按照配方比例,将D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、果胶分解物、柠檬酸粉碎,过60-120目筛,然后与包埋益生菌粉剂、β-胡萝卜素、牛奶香精、硬脂酸镁混合3-15min即得保健食品粉剂。2) According to the formula ratio, D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharide, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, fruit Gum decomposition products and citric acid are pulverized, passed through a 60-120 mesh sieve, and then mixed with embedded probiotic powder, β-carotene, milk essence, and magnesium stearate for 3-15 minutes to obtain a health food powder.
本发明植物乳杆菌(Lactobacillus plantarum)tlj-2014已于2014年7月2日保藏于中国微生物菌种保藏管理委员会普通微生物中心(简称CGMCC,地址为:中国北京市朝阳区北辰西路1号院3号.中国科学院微生物研究所.邮编:100101),保藏编号为CGMCC NO.9405,分类命名为:植物乳杆菌Lactobacillus plantarum。The present invention Lactobacillus plantarum (Lactobacillus plantarum) tlj-2014 has been preserved on July 2, 2014 in the General Microbiology Center of the China Microbiological Culture Collection Management Committee (abbreviated as CGMCC, the address is: No. 1, Beichen West Road, Chaoyang District, Beijing, China No. 3. Institute of Microbiology, Chinese Academy of Sciences. Zip code: 100101), the preservation number is CGMCC NO.9405, and the classification name is Lactobacillus plantarum.
所述植物乳杆菌菌株特点如下:在显微镜下观察,该菌株为短杆状,革兰氏染色呈阳性,无鞭毛,不产芽孢;在固体培养基上,该菌菌落为白色,表面光滑,致密,形态为圆形,边缘较整齐。The characteristics of the Lactobacillus plantarum strain are as follows: observed under a microscope, the bacterial strain is short rod-shaped, Gram staining is positive, without flagella, and does not produce spores; on a solid medium, the bacterial colony is white with a smooth surface. Dense, round shape with neat edges.
理化特征为:过氧化氢酶(-),明胶液化(-),吲哚实验(+),运动性(-),发酵产气(-),亚硝酸盐还原(-),发酵产气(-),产硫化氢气体(-),pH4.0MRS培养基中生长(+)。The physical and chemical characteristics are: catalase (-), gelatin liquefaction (-), indole test (+), motility (-), fermentation gas production (-), nitrite reduction (-), fermentation gas production ( -), produce hydrogen sulfide gas (-), grow in pH4.0 MRS medium (+).
所述植物乳杆菌采用下述流程进行选育:The plantarum lactobacillus adopts the following procedures to select and breed:
原始出发菌种→试管活化→硫酸二乙酯(DES)诱变→亚硝基胍(NTG)诱变→等离子体诱变→平板初筛→摇瓶复筛→传代稳定性试验。Original starting strain → test tube activation → diethyl sulfate (DES) mutagenesis → nitrosoguanidine (NTG) mutagenesis → plasma mutagenesis → plate primary screening → shake flask secondary screening → passage stability test.
所述出发菌株在MRS葡萄糖培养基中,其乳酸的生产速率为1.5g/L/d,当培养基pH为3.5时几乎停止生长,对亚硝酸钠的分解速率为0.34mg/h/kg白菜。出发菌株为李政采集于宁夏盐池县育肥羊场的青储饲料,采集时间2013年9月15日。The starting strain is in the MRS glucose medium, its lactic acid production rate is 1.5g/L/d, when the pH of the medium is 3.5, it almost stops growing, and the decomposition rate of sodium nitrite is 0.34mg/h/kg cabbage . The starting strain was the silage feed collected by Li Zheng on the fattening sheep farm in Yanchi County, Ningxia, and the collection time was September 15, 2013.
为了提高其乳酸生产速率、耐酸能力和亚硝酸盐的分解速率,依次采用DES和NTG技术对该菌种进行诱变,诱变后菌株采用MRS碳酸钙平板进行初筛,然后采用500mL摇瓶发酵,生物传感器分析仪对高产菌进行复筛,选育优良的植物乳杆菌菌株,然后做传代实验,评价其遗传稳定性。In order to improve its lactic acid production rate, acid resistance and nitrite decomposition rate, the strain was mutated by using DES and NTG techniques in sequence. After the mutagenesis, the strain was screened with MRS calcium carbonate plate, and then fermented in a 500mL shake flask. , The biosensor analyzer re-screens high-yield bacteria, selects and breeds excellent Lactobacillus plantarum strains, and then conducts passage experiments to evaluate their genetic stability.
植物乳杆菌tlj-2014遗传稳定性结果表明:经过连续传代十次,各项性能指标都比较稳定,遗传性较好,性状没有回复,因此把植物乳杆菌tlj-2014作为选育得到的目的菌株。The results of the genetic stability of Lactobacillus plantarum tlj-2014 show that after ten consecutive passages, all performance indicators are relatively stable, heredity is good, and the traits have not recovered. Therefore, Lactobacillus plantarum tlj-2014 is used as the target strain obtained by selection. .
经验证发现:该诱变菌株的乳酸生产速率可以达到35g/L/d,该菌株经过71小时发酵后乳酸浓度达到95g/L;能够在pH为1.80的条件下存活。降解亚硝酸盐速度快,分解能力达到9.8mg/h/kg(自然发酵过程亚硝酸盐积累的速率大约为1.1mg/h/kg),能够耐1%胆盐。After verification, it was found that the lactic acid production rate of the mutant strain can reach 35g/L/d, and the lactic acid concentration of the strain can reach 95g/L after 71 hours of fermentation; it can survive under the condition of pH 1.80. The degradation rate of nitrite is fast, the decomposition capacity reaches 9.8mg/h/kg (the rate of nitrite accumulation in the natural fermentation process is about 1.1mg/h/kg), and it can tolerate 1% bile salt.
因此采用该菌种生产泡菜,整个发酵过程中亚硝酸盐浓度在5mg/kg以下,远低于国家标准GB2714-2003中规定的含量(20mg/kg)。Therefore adopt this bacterial classification to produce kimchi, the nitrite concentration is below 5mg/kg in the whole fermentation process, is far lower than the content (20mg/kg) stipulated in the national standard GB2714-2003.
有益效果:Beneficial effect:
本发明可改善肠道菌群的保健食品从增加益生菌种类和数量、增加益生菌营养物质、抑制有害菌生长及增加人体免疫力等多方面调整肠道菌群,改善胃肠功能。以植物乳杆菌等益生菌粉剂为主要原料,科学复配可修复细胞组织、具有抗溃疡作用、抗氧化作用、清除自由基作用和抗衰老作用,可显著提升人体整体免疫力和增强体力、改善胃肠功能的食用菌提取物;含有高含量可溶性纤维素的改性膳食纤维;可显著提高人体免疫力、抗炎镇痛、具有抗氧化、抗辐射和抗疲劳等功能的雪莲培养物提取物等为原料,进而在增加肠道益生菌菌群种类的同时,显著增强了内源和外源益生菌在人体肠道内的定植能力及定植时间,有效抑制了肠道有害菌尤其是革兰氏阴性菌的生长及繁殖,充分调节了肠道益生菌菌群的组成,制备出一种益生性强、显著提高人体免疫力、可改善肠道菌群的保健食品。具体技术原理为:The health food that can improve intestinal flora can adjust intestinal flora and improve gastrointestinal function by increasing the types and quantities of probiotics, increasing the nutrients of probiotics, inhibiting the growth of harmful bacteria, increasing human immunity and the like. Using probiotic powder such as Lactobacillus plantarum as the main raw material, scientific compound can repair cell tissue, have anti-ulcer effect, anti-oxidation effect, free radical scavenging effect and anti-aging effect, which can significantly improve the overall immunity of the human body and enhance physical strength, improve Edible fungus extract with gastrointestinal function; modified dietary fiber containing high content of soluble cellulose; Saussurea officinalis culture extract that can significantly improve human immunity, anti-inflammatory and analgesic, and has anti-oxidation, anti-radiation and anti-fatigue functions etc. as raw materials, while increasing the types of intestinal probiotic flora, it significantly enhanced the colonization ability and colonization time of endogenous and exogenous probiotics in the human intestinal tract, and effectively inhibited intestinal harmful bacteria, especially Gram The growth and reproduction of negative bacteria can fully regulate the composition of intestinal probiotic flora, and prepare a health food with strong probiotic properties, significantly improve human immunity, and improve intestinal flora. The specific technical principles are:
1.本发明可改善肠道菌群的保健食品益生菌种类多,其中的植物乳杆菌CGMCC NO.9405乳酸生产速率可以达到35g/L/d,该菌株经过71小时发酵后乳酸浓度达到95g/L;能够在pH为1.80的条件下存活。降解亚硝酸盐速度快,分解能力达到9.8mg/h/kg(自然发酵过程亚硝酸盐积累的速率大约为1.1mg/h/kg),能够耐1%胆盐,其益生性能更加优越。1. There are many kinds of health food probiotics that can improve intestinal flora in the present invention, among which the lactic acid production rate of Lactobacillus plantarum CGMCC NO.9405 can reach 35g/L/d, and the lactic acid concentration of the strain can reach 95g/L/d after 71 hours of fermentation L; able to survive at a pH of 1.80. The speed of degrading nitrite is fast, and the decomposition capacity reaches 9.8mg/h/kg (the rate of nitrite accumulation in the natural fermentation process is about 1.1mg/h/kg), and it can tolerate 1% bile salt, and its probiotic performance is even more superior.
2.本发明制备的改性膳食纤维将超声提取、高压脉冲电场提取和生物酶解科学结合,所得改性膳食纤维可溶性纤维素含量高,更容易被益生菌利用,提高益生菌在肠道的生长及繁殖能力,增加益生菌菌群的种类和数量,降低大肠pH值,改善肠道微生态环境;吸附能力强,经改性后,纤维素的比表面积增大,网格结构丰富,吸附力增强,螯合、吸附胆固醇和胆汁酸类的有机分子能力更强、抑制人体对他们的吸收;离子交换能力增强,对金属元素,特别是重金属元素吸附效果更强,有效防止了人体重金属中毒;持水性、膨胀性、增稠性更强且不受酸、碱、盐的影响。调节和维持肠道菌群的定植时间,增强肠道的消化和吸收能力,提高人体免疫力;有效促进胃肠蠕动,减缓并消除胃胀、腹胀等不良反应;强大的包埋作用可防止外界环境(氧气、温度、光照、湿度等)因素对产品品质的影响,稳定了产品的生物活性,延长了产品的保质期。2. The modified dietary fiber prepared by the present invention combines ultrasonic extraction, high-voltage pulse electric field extraction and biological enzymatic hydrolysis scientifically. The obtained modified dietary fiber has a high content of soluble cellulose and is easier to be used by probiotics. Growth and reproduction ability, increase the type and quantity of probiotic flora, reduce the pH value of the large intestine, and improve the intestinal micro-ecological environment; strong adsorption capacity, after modification, the specific surface area of cellulose increases, the grid structure is rich, and the adsorption The ability to chelate and adsorb organic molecules of cholesterol and bile acids is stronger and inhibit the absorption of them by the human body; the ion exchange ability is enhanced, and the adsorption effect on metal elements, especially heavy metal elements, is stronger, which effectively prevents human body from heavy metal poisoning ;Water holding capacity, swelling property and thickening property are stronger and not affected by acid, alkali and salt. Regulate and maintain the colonization time of intestinal flora, enhance the digestion and absorption capacity of the intestinal tract, and improve human immunity; effectively promote gastrointestinal motility, slow down and eliminate adverse reactions such as gastric distension and abdominal distension; strong embedding effect can prevent external The impact of environmental factors (oxygen, temperature, light, humidity, etc.) on product quality stabilizes the biological activity of the product and prolongs the shelf life of the product.
3.本发明制备的食用菌提取物是以修复细胞组织、具有抗溃疡作用、抗氧化作用、清除自由基作用和抗衰老作用,可显著提升人体整体疫免力和增强体力、改善胃肠功能的食用菌经超声清洗、高压脉冲电场处理和生物酶解得到的,有效成分提取率高,食用菌酶解液中食用菌多糖含量高达6.82%,生物活性更强,食品安全性高,无农药及虫卵残留。3. The edible fungus extract prepared by the present invention is to repair cell tissue, have anti-ulcer effect, anti-oxidation effect, free radical scavenging effect and anti-aging effect, which can significantly improve the overall immunity of the human body, enhance physical strength, and improve gastrointestinal function The edible fungus is obtained by ultrasonic cleaning, high-voltage pulse electric field treatment and biological enzymolysis. The extraction rate of active ingredients is high. The edible fungus polysaccharide content in the edible fungus enzymatic solution is as high as 6.82%, with stronger biological activity, high food safety, and no pesticides. and egg residues.
4.本发明制备的雪莲培养物提取物是以具有镇痛、抗炎、抗风湿;抑制血小板聚集、降血脂、改善血液循环;对免疫系统具有调节作用;同时还有抗氧化、抗辐射和抗疲劳等多方面的药效学作用的天山雪莲为种源的雪莲培养物为原料经冷冻、粉碎、微波辅助超声提取、低温酶解、高压脉冲电场提取等低温提取技术而制得,可最大限度地保留金合欢素、粗毛豚草素、芦丁、槲皮素等黄酮类物质和其它抗氧化、易挥发、热敏性有效成分,有效成分获取率高,工艺简单、时间短,提高了原料利用率,降低了生产成本,提高了生产效率。试验证明,本发明制备的雪莲培养物提取物黄酮得率可达97%,固形物得率可达65%。且雪莲细胞培养物不再含有对人体有副作用的秋水仙碱,卫生部已于2010年5月20日批准雪莲培养物为新资源食品,对推动我国中药现代化、保护野生植物资源、发展社会经济具有重要意义。4. The snow lotus culture extract prepared by the present invention has analgesic, anti-inflammatory, anti-rheumatism; inhibits platelet aggregation, lowers blood fat, improves blood circulation; has a regulatory effect on the immune system; also has anti-oxidation, anti-radiation and Anti-fatigue and other pharmacodynamic effects, the Tianshan Saussurea involucrata is the origin of the Saussurea chinensis culture as the raw material, which is obtained by low-temperature extraction techniques such as freezing, crushing, microwave-assisted ultrasonic extraction, low-temperature enzymolysis, and high-voltage pulse electric field extraction. Flavonoids such as acacetin, ragragpinin, rutin, quercetin and other anti-oxidation, volatile, heat-sensitive active ingredients are retained to a maximum extent, the effective ingredient acquisition rate is high, the process is simple, the time is short, and the utilization of raw materials is improved. rate, reducing production costs and improving production efficiency. Tests have proved that the flavonoid yield of the snow lotus culture extract prepared by the invention can reach 97%, and the solid content yield can reach 65%. And the Saussurea sauraceae cell culture no longer contains colchicine, which has side effects on the human body. The Ministry of Health has approved the Saussurea sauraceae culture as a new resource food on May 20, 2010. is of great significance.
5.本发明制备的果胶分解物具有天然、柔和适口的酸味和显著的抑菌特性,尤其对大肠杆菌抑制作用最强,同时还具有较强的抗氧化性,浓度达到0.01%时即可作用,对超氧自由基、羟自由基和DPPH自由基都表现出很强的消除作用,当浓度达到1.0%时,消除效果达到100%;果胶分解物的科学复配,可有效提高本发明保健食品的适口性,最主要的是其显著的抑菌特性和抗氧化性避免了有效成分的氧化和微生物侵害,稳定和提高了产品的生物活性,延长了产品的保质期。5. The pectin decomposition product prepared by the present invention has a natural, soft and palatable sour taste and significant antibacterial properties, especially the strongest inhibitory effect on Escherichia coli, and also has strong antioxidant properties, and the concentration can reach 0.01%. It has a strong elimination effect on superoxide free radicals, hydroxyl radicals and DPPH free radicals. When the concentration reaches 1.0%, the elimination effect reaches 100%. The scientific compounding of pectin decomposition products can effectively improve this The most important thing about the palatability of the invented health food is that its remarkable antibacterial properties and anti-oxidation properties avoid the oxidation of active ingredients and microbial damage, stabilize and improve the biological activity of the product, and prolong the shelf life of the product.
6.本发明科学复配的异麦芽酮糖醇具有低热量、甜度天然纯正、高耐受性、非致龋齿性、较合理的负溶解热、高稳定性和非吸湿性,在提升产品的品质、延长保质期、促进胃肠消化和吸收方面具有优良的特性,同时还是一种优良的双歧杆菌增殖因子,虽然异麦芽酮糖醇不能被人体和绝大多数微生物的酶系所利用,但却可以被人体肠道中的双歧杆菌所分解利用,促进双歧杆菌的生长繁殖,维持肠道的微生态平衡,提高人体整体免疫力,有利于人体的健康。6. The scientifically compounded isomalt of the present invention has low calorie, natural and pure sweetness, high tolerance, non-cariogenicity, reasonable negative heat of solution, high stability and non-hygroscopicity. It has excellent characteristics in terms of quality, extended shelf life, and promotion of gastrointestinal digestion and absorption. It is also an excellent bifidobacteria proliferation factor. Although isomalt cannot be used by the human body and the enzyme system of most microorganisms, However, it can be decomposed and utilized by bifidobacteria in the human intestinal tract to promote the growth and reproduction of bifidobacteria, maintain the micro-ecological balance of the intestinal tract, improve the overall immunity of the human body, and benefit the health of the human body.
7.本发明可改善肠道菌群的保健食品的效果是各组分相互协同作用的结果,并非简单的原料功能的叠加,各原料组分的科学复配,产生的效果远远超过各单一组份功能和效果的叠加,具有较好的先进性和实用性。7. The effect of the health food that can improve the intestinal flora of the present invention is the result of the synergistic effect of each component, not simply the superposition of raw material functions, the scientific compounding of each raw material component, the effect produced is far more than each single The superposition of component functions and effects has good advancement and practicality.
8.本发明可改善肠道菌群的保健食品的制备方法工艺简单,操作方便,对设备要求低,可工业化和规模化生产,将改性膳食纤维最后混合,发挥了其强大的包埋作用,使得产品的性状更稳定、保质期更长。8. The preparation method of the health food that can improve the intestinal flora of the present invention is simple, easy to operate, low in equipment requirements, and can be industrialized and large-scale production. The modified dietary fiber is finally mixed to exert its powerful embedding effect , making the properties of the product more stable and the shelf life longer.
具体实施方式detailed description
下面通过具体的实施方案叙述本发明。除非特别说明,本发明中所用的技术手段均为本领域技术人员所公知的方法。另外,实施方案应理解为说明性的,而非限制本发明的范围,本发明的实质和范围仅由权利要求书所限定。对于本领域技术人员而言,在不背离本发明实质和范围的前提下,对这些实施方案中的物料成分和用量进行的各种改变或改动也属于本发明的保护范围。The present invention is described below through specific embodiments. Unless otherwise specified, the technical means used in the present invention are methods known to those skilled in the art. In addition, the embodiments should be considered as illustrative rather than limiting the scope of the invention, the spirit and scope of which is defined only by the claims. For those skilled in the art, on the premise of not departing from the spirit and scope of the present invention, various changes or modifications to the material components and dosage in these embodiments also belong to the protection scope of the present invention.
实施例1原料制备Embodiment 1 raw material preparation
1.植物乳杆菌粉剂的制备:1. Preparation of Lactobacillus plantarum powder:
(1)一级种子培养:将植物乳杆菌CGMCC NO.9405菌种接入500毫升摇瓶中,种子培养基装量100毫升,培养温度37℃,培养时间24小时;(1) Primary seed culture: Inoculate Lactobacillus plantarum CGMCC NO.9405 into a 500 ml shaker flask, with a seed medium capacity of 100 ml, a culture temperature of 37°C, and a culture time of 24 hours;
(2)二级种子培养:将一级种子按照10%的接种量接入500毫升二级种子摇瓶中,培养条件与一级种子相同;(2) secondary seed cultivation: the primary seed is inserted into a 500 milliliter secondary seed shake flask according to the inoculum size of 10%, and the cultivation condition is the same as that of the primary seed;
(3)三级种子培养:将二级种子以10%接种量接入5000毫升三级种子摇瓶中,种子培养基装量1000毫升,培养温度37℃,培养时间24小时;(3) Tertiary seed cultivation: insert the secondary seeds with 10% inoculum size into 5000 milliliters of the tertiary seed shaking flask, the seed culture medium loading capacity is 1000 milliliters, the cultivation temperature is 37 ℃, and the cultivation time is 24 hours;
(4)一级种子罐培养:将三级种子以5%接种量接入总容积为150L的一级种子罐,发酵培养基装量100L,培养温度37℃,罐压0.05MPa,培养时间18小时;(4) First-level seed tank cultivation: put the third-level seeds into the first-level seed tank with a total volume of 150L with 5% inoculation amount, the fermentation medium capacity is 100L, the culture temperature is 37°C, the tank pressure is 0.05MPa, and the culture time is 18 Hour;
(5)发酵罐培养:将一级种子罐菌种以5%接种量接入总容积为3吨二级种子罐,发酵培养基装量2吨,培养条件培养温度37℃,罐压0.05MPa,培养时间22小时。发酵完毕发酵液静置沉淀、离心得到沉淀物,然后添加沉淀物质量0.8倍的载体,混合均匀,50℃流化床干燥即得植物乳杆菌粉剂,载体重量组成为:酸奶粉25份,糊精12份。(5) Fermentation tank culture: the strains of the first-level seed tank are inserted into the second-level seed tank with a total volume of 3 tons with 5% inoculation amount, the fermentation medium loading capacity is 2 tons, and the culture conditions are 37°C, 0.05MPa tank pressure , The incubation time was 22 hours. After the fermentation, the fermented liquid was left to settle and centrifuged to obtain the precipitate, then a carrier 0.8 times the weight of the precipitate was added, mixed evenly, and dried in a fluidized bed at 50°C to obtain Lactobacillus plantarum powder. The weight composition of the carrier was: 25 parts of yogurt powder, paste Refined 12 parts.
所述种子培养基质量组成为:酪蛋白1%,牛肉膏1%,酵母浸膏0.5%,葡萄糖0.5%,乙酸钠0.5%,柠檬酸二胺0.2%,Tween 800.1%,K2HPO40.2%,MgSO4.7H2O 0.02%,MnSO4.H2O 0.005%,CaCO32%,余量为水,pH6.8。The quality composition of the seed medium is: 1% casein, 1% beef extract, 0.5% yeast extract, 0.5% glucose, 0.5% sodium acetate, 0.2% diamine citrate, 800.1% Tween, K 2 HPO 4 0.2 %, MgSO 4 .7H 2 O 0.02%, MnSO 4 .H 2 O 0.005%, CaCO 3 2%, the balance is water, pH6.8.
所述发酵培养基质量组成为:大豆蛋白1%,牛肉提取物1%,酵母提取物0.5%,葡萄糖0.5%,乙酸钠0.5%,柠檬酸二胺0.2%,K2HPO40.2%,MgSO4.7H2O 0.02%,MnSO4.H2O 0.005%,CaCO32%,余量为水,pH6.8。The quality composition of the fermentation medium is: soybean protein 1%, beef extract 1%, yeast extract 0.5%, glucose 0.5%, sodium acetate 0.5%, citrate diamine 0.2%, K 2 HPO 4 0.2%, MgSO 4.7H 2 O 0.02%, MnSO 4 .H 2 O 0.005%, CaCO 3 2%, the balance is water, pH6.8.
所述植物乳杆菌粉剂中活菌含量为9x1012cfu/g。The live bacteria content in the Lactobacillus plantarum powder is 9× 10 12 cfu/g.
2.改性膳食纤维的制备2. Preparation of modified dietary fiber
所述改性膳食纤维的制备方法包括以下步骤:将菊粉、苹果纤维、燕麦纤维、小麦纤维按质量比9:5:4:3均匀混合,加入其质量5倍的水,室温300W、40KHz条件超声提取12min,然后在电场强度30kV/cm,脉冲时间500μs,脉冲频率300Hz条件下进行高压脉冲电场提取;用乳酸调节pH值为5.0,加入混合物质量0.2%的生物酶,于50℃酶解35min;酶解液减压浓缩、冷冻干燥、低温粉碎至粒径为0.2mm即得改性膳食纤维;The preparation method of the modified dietary fiber comprises the following steps: uniformly mixing inulin, apple fiber, oat fiber, and wheat fiber in a mass ratio of 9:5:4:3, adding water five times its mass, and heating at room temperature 300W, 40KHz Ultrasonic extraction for 12 minutes, and then high-voltage pulsed electric field extraction under the conditions of electric field strength 30kV/cm, pulse time 500μs, and pulse frequency 300Hz; adjust the pH value to 5.0 with lactic acid, add 0.2% of the mixture’s mass of biological enzymes, and enzymolyze at 50°C 35min; the enzymatic solution was concentrated under reduced pressure, freeze-dried, and crushed at low temperature until the particle size was 0.2mm to obtain the modified dietary fiber;
所述生物酶为木聚糖酶、纤维素酶、漆酶、果胶酶、单宁酶按质量比7:3:3:3:2均匀混合。The biological enzymes are xylanase, cellulase, laccase, pectinase and tannase, which are uniformly mixed in a mass ratio of 7:3:3:3:2.
3.食用菌提取物的制备3. Preparation of Edible Fungi Extract
所述食用菌提取物的制备方法包括如下步骤:将猴头菇、银杏和黑木耳分别放入装有0.4%碳酸氢钠溶液的超声波清洗机中于200W、40KHz清洗8min,沥干,切分成相等规格,长、宽为5-10mm,厚度3-5mm的片或丁,按质量比按质量比9:6:5均匀混合,然后于-23℃冷冻20min,立即进行粉碎,粉碎物粒径为0.5mm;加入粉碎物质量4倍的水得混合物,调整混合物pH为5.2,室温下在电场强度40kV/cm,脉冲时间600μs,脉冲频率300Hz条件下进行高压脉冲电场处理,升温至50℃,加入混合物重量0.8%的混合酶酶解5小时,得到食用菌酶解液,减压浓缩至固形物含量为30%以上,冷冻干燥、低温粉碎至粒径为0.2mm即得食用菌提取物;The preparation method of the edible mushroom extract comprises the steps of: putting Hericium erinaceus, ginkgo biloba and black fungus into an ultrasonic cleaning machine equipped with 0.4% sodium bicarbonate solution respectively, cleaning at 200W and 40KHz for 8min, draining, and cutting into Tablets or dices of equal specifications, length and width 5-10mm, thickness 3-5mm, mixed uniformly according to the mass ratio of 9:6:5, then frozen at -23°C for 20min, and immediately crushed, the particle size of the crushed product 0.5 mm; add water 4 times the amount of crushed material to obtain a mixture, adjust the pH of the mixture to 5.2, conduct high-voltage pulse electric field treatment under the conditions of electric field strength 40kV/cm, pulse time 600μs, and pulse frequency 300Hz at room temperature, and heat up to 50°C. Add 0.8% of the weight of the mixture to enzymolyze the enzyme for 5 hours to obtain the edible fungus enzymatic hydrolyzate, concentrate under reduced pressure until the solid content is more than 30%, freeze-dry, and crush at low temperature until the particle size is 0.2mm to obtain the edible fungus extract;
所述食用菌酶解液中食用菌多糖含量高达6.82%;The edible fungus polysaccharide content in the edible fungi enzymatic solution is as high as 6.82%;
所述混合酶重量份数组成为:木瓜蛋白酶25份,菠萝蛋白酶25份,葡聚糖酶12份,木聚糖酶12份,戊聚糖酶12份,无花果蛋白酶8份,中温淀粉酶8份,果胶酶7份,单宁酶4份。The number of parts by weight of the mixed enzyme is: 25 parts of papain, 25 parts of bromelain, 12 parts of dextranase, 12 parts of xylanase, 12 parts of pentosanase, 8 parts of ficinase, and 8 parts of mesophilic amylase , 7 parts of pectinase, 4 parts of tannase.
4.雪莲培养物提取物的制备4. Preparation of Snow Lotus Culture Extract
所述雪莲培养物提取物的制备方法包括如下步骤:取雪莲培养物,浸入盛有质量百分比浓度为1.0%的无菌低聚果糖水溶液的容器中,取出,然后于-20℃冷冻8min;立即粉碎至粒径0.5mm;置容器中并添加4倍重量的40%的乙醇,得混合物料,用乳酸调节pH值为4.5,于室温下在电场强度30kV/cm,脉冲时间400μs,脉冲频率250Hz条件下进行高压脉冲电场处理;然后升温至35℃,保温,在功率200W、频率2000Hz条件下进行微波提取,其中,每次微波辐照总时间70s,进行间隔式辐照:辐照10s,间隔10s,如此辐照10次,同时在功率250W,频率35KHz条件下进行超声波辅助提取;继续升温至45℃,保温,然后加入混合物料总重量3.3%的复配酶酶解40min,过滤,得滤液;滤渣用2倍重量78℃水漂洗3次,漂洗液与滤液合并,均匀混合,于室温下在电场强度40kV/cm,脉冲时间500μs,脉冲频率250Hz条件下进行高压脉冲电场处理即得雪莲培养物提取物;The preparation method of the snow lotus culture extract comprises the following steps: taking the snow lotus culture, immersing it in a container filled with a sterile fructo-oligosaccharide aqueous solution with a mass percentage concentration of 1.0%, taking it out, and then freezing it at -20°C for 8 minutes; immediately Grind to a particle size of 0.5mm; put it in a container and add 4 times the weight of 40% ethanol to obtain a mixed material, adjust the pH value to 4.5 with lactic acid, and set the electric field strength at 30kV/cm at room temperature, pulse time 400μs, pulse frequency 250Hz Carry out high-voltage pulse electric field treatment under the condition; then raise the temperature to 35°C, keep warm, and carry out microwave extraction under the condition of power 200W and frequency 2000Hz, wherein, the total time of each microwave irradiation is 70s, and interval irradiation is carried out: irradiation 10s, interval 10s, so irradiated 10 times, and at the same time, carry out ultrasonic-assisted extraction under the condition of power 250W, frequency 35KHz; continue to heat up to 45°C, keep warm, then add a compound enzyme with a total weight of 3.3% of the mixed material to enzymatically hydrolyze for 40min, filter to obtain the filtrate The filter residue is rinsed 3 times with 2 times the weight of 78°C water, the rinsing liquid and the filtrate are combined, mixed evenly, and the high-voltage pulse electric field treatment is carried out under the conditions of electric field strength 40kV/cm, pulse time 500μs, and pulse frequency 250Hz at room temperature to obtain the snow lotus culture plant extracts;
所述复配酶由果胶酶、纤维素酶、单宁酶、淀粉酶和蛋白酶按质量比5:4:3:2:1.5均匀混合。The compound enzyme is uniformly mixed with pectinase, cellulase, tannase, amylase and protease in a mass ratio of 5:4:3:2:1.5.
5.果胶分解物的制备5. Preparation of Pectin Decomposition Products
所述果胶分解物的制备方法,包括如下步骤:将新鲜的山楂果渣、柚皮、苹果渣、甜菜渣分别放入装有1.2%碳酸氢钠溶液的超声波清洗机中于200W、40KHz清洗8min,沥干,切分成相等规格,长、宽为5-10mm,厚度3-5mm的片或丁,按质量比10:4:3:3均匀混合,然后于-23℃冷冻20min;立即进行粉碎,粉碎物粒径为0.5mm;加入粉碎物质量4倍的去离子水,混合均匀,用柠檬酸调节pH值为2.5,室温下在电场强度40kV/cm,脉冲时间600μs,脉冲频率300Hz条件下进行高压脉冲电场处理,接着常压煮沸40min,布袋过滤,滤渣用其质量2倍的滤液常压煮沸50min,布袋过滤,合并滤液,硅藻土过滤,使滤液澄清,在75℃下减压浓缩至固形物含量为8%,迅速冷却至室温,加入浓缩液1.5倍体积的pH值为2.5的95%乙醇,静置25min,使果胶沉淀出来,4000r/min离心8min,回收沉淀,用2倍体积的无水乙醇洗脱,离心,回收沉淀,如此操作2次,得到的沉淀于50℃真空干燥2.5h,获得果胶,加入果胶质量4.5倍的45℃水,搅拌,均匀混合,保温,用乳酸调节pH值为5,加入0.5U/mL的果胶酶酶解3h,酶解液过滤,滤液于沸水中灭酶12min,冷却至室温,超滤浓缩、冷冻干燥即得果胶分解物。The preparation method of the pectin decomposition product comprises the following steps: putting fresh hawthorn pomace, pomelo peel, apple pomace, and sugar beet pomace into an ultrasonic cleaning machine equipped with 1.2% sodium bicarbonate solution and cleaning at 200W and 40KHz Drain for 8 minutes, cut into slices or dices of equal size, length and width 5-10mm, thickness 3-5mm, mix evenly according to the mass ratio of 10:4:3:3, and then freeze at -23°C for 20 minutes; proceed immediately Grinding, the particle size of the pulverized material is 0.5mm; add deionized water 4 times the amount of the pulverized material, mix well, adjust the pH value to 2.5 with citric acid, at room temperature under the conditions of electric field strength 40kV/cm, pulse time 600μs, pulse frequency 300Hz Carry out high-voltage pulse electric field treatment under normal pressure, then boil at normal pressure for 40 minutes, filter with cloth bag, boil the filter residue with filtrate twice its mass under normal pressure for 50 minutes, filter with cloth bag, combine filtrate, filter with diatomaceous earth, make filtrate clarified, and reduce pressure at 75°C Concentrate to a solid content of 8%, quickly cool to room temperature, add 95% ethanol with a pH value of 2.5 to 1.5 times the volume of the concentrated solution, let it stand for 25 minutes to precipitate the pectin, centrifuge at 4000r/min for 8 minutes, recover the precipitate, and use Elute with 2 times the volume of absolute ethanol, centrifuge, and recover the precipitate. Do this twice. The obtained precipitate is vacuum-dried at 50°C for 2.5 hours to obtain pectin. Add 4.5 times the mass of pectin in 45°C water, stir, and mix evenly , keep warm, adjust the pH value to 5 with lactic acid, add 0.5U/mL pectinase to enzymolyze for 3 hours, filter the enzymatic solution, inactivate the filtrate in boiling water for 12 minutes, cool to room temperature, concentrate by ultrafiltration, and freeze-dry to obtain the fruit Glue decomposition.
以下实施例所使用的植物乳杆菌粉剂、改性膳食纤维、食用菌提取物、雪莲培养物提取物、果胶分解物均为实施例1制备,其它原料为市购商品。The Lactobacillus plantarum powder, modified dietary fiber, edible fungus extract, snow lotus culture extract, and pectin decomposition product used in the following examples were all prepared in Example 1, and other raw materials were commercially available.
实施例2Example 2
一种可改善肠道菌群的保健食品片剂,由以下重量份数的原料制备:A health food tablet capable of improving intestinal flora, prepared from the following raw materials in parts by weight:
D-甘露糖醇25份,麦芽糊精15份,微晶纤维素15份,益生菌粉剂15份,改性膳食纤维10份,低聚木糖9份,异麦芽酮糖醇9份,浓缩乳清蛋白9份,食用菌提取物8份,雪莲培养物提取物7份,果胶分解物6份,α-环状糊精3份,柠檬酸2份,硬脂酸镁2份,牛奶香精2份,β-胡萝卜素1.5份;25 parts of D-mannitol, 15 parts of maltodextrin, 15 parts of microcrystalline cellulose, 15 parts of probiotic powder, 10 parts of modified dietary fiber, 9 parts of xylooligosaccharide, 9 parts of isomalt, concentrated 9 parts of whey protein, 8 parts of edible mushroom extract, 7 parts of snow lotus culture extract, 6 parts of pectin decomposition product, 3 parts of α-cyclodextrin, 2 parts of citric acid, 2 parts of magnesium stearate, milk 2 parts of essence, 1.5 parts of β-carotene;
所述益生菌粉剂由以下重量份数的粉剂均匀混合而成:植物乳杆菌45份,长双歧杆菌38份,两岐双岐杆菌30份,青春双岐杆菌18份,保加利亚乳杆菌18份,嗜酸乳杆菌12份,干酪乳杆菌9份,嗜热链球菌9份,酿酒酵母9份,产朊假丝酵母菌5份;The probiotic powder is uniformly mixed with the following powders by weight: 45 parts of Lactobacillus plantarum, 38 parts of Bifidobacterium longum, 30 parts of Bifidobacterium bifidus, 18 parts of Bifidobacterium adolescent, and 18 parts of Lactobacillus bulgaricus , 12 parts of Lactobacillus acidophilus, 9 parts of Lactobacillus casei, 9 parts of Streptococcus thermophilus, 9 parts of Saccharomyces cerevisiae, 5 parts of Candida utilis;
所述益生菌粉剂益生菌活菌含量为:9x1012cfu/g;The probiotic live bacteria content of the probiotic powder is: 9× 10 12 cfu/g;
制备方法,包括如下步骤:The preparation method comprises the steps of:
1)按照配方比例,分别取D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、牛奶香精粉碎,过80目筛,然后混合10min,得混合粉;1) Take D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharides, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, The milk essence is crushed, passed through an 80-mesh sieve, and then mixed for 10 minutes to obtain a mixed powder;
2)将果胶分解物、柠檬酸、β-胡萝卜素溶于水中制成15%的水溶液,作为粘合剂;2) dissolving pectin decomposition products, citric acid, and β-carotene in water to make a 15% aqueous solution as a binder;
3)向所述混合粉中加入所述粘合剂制成软材,用16目筛制粒,得湿颗粒,置微波干燥机中于功率3000W、频率2450MHz、温度60℃干燥5min,用16目筛快速整粒;3) Add the binder to the mixed powder to make a soft material, granulate with a 16-mesh sieve to obtain wet granules, and dry them in a microwave dryer at a power of 3000W, a frequency of 2450MHz, and a temperature of 60°C for 5min, and use 16 Mesh sieve fast granulation;
4)将改性膳食纤维、α-环状糊精和益生菌粉混合8min,得包埋益生菌粉剂;4) Mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 8 minutes to obtain the embedded probiotic powder;
5)整好的颗粒与包埋益生菌粉剂、硬脂酸镁混合8min,混合均匀后,压片、包装即得保健食品片剂。5) Mix the prepared granules with the embedded probiotic powder and magnesium stearate for 8 minutes, and after mixing evenly, press into tablets and pack to obtain health food tablets.
实施例3Example 3
一种可改善肠道菌群的保健食品片剂,由以下重量份数的原料制备:A health food tablet capable of improving intestinal flora, prepared from the following raw materials in parts by weight:
D-甘露糖醇15份,麦芽糊精10份,微晶纤维素10份,益生菌粉剂10份,改性膳食纤维8份,低聚木糖7份,异麦芽酮糖醇7份,浓缩乳清蛋白7份,食用菌提取物5份,雪莲培养物提取物5份,果胶分解物5份,α-环状糊精1.5份,柠檬酸1.5份,硬脂酸镁1.5份,牛奶香精1.5份,β-胡萝卜素1份;15 parts of D-mannitol, 10 parts of maltodextrin, 10 parts of microcrystalline cellulose, 10 parts of probiotic powder, 8 parts of modified dietary fiber, 7 parts of xylooligosaccharide, 7 parts of isomalt, concentrated 7 parts of whey protein, 5 parts of edible mushroom extract, 5 parts of snow lotus culture extract, 5 parts of pectin decomposition product, 1.5 parts of α-cyclodextrin, 1.5 parts of citric acid, 1.5 parts of magnesium stearate, milk 1.5 parts of essence, 1 part of β-carotene;
所述益生菌粉剂由以下重量份数的粉剂均匀混合而成:植物乳杆菌40份,长双歧杆菌30份,两岐双岐杆菌25份,青春双岐杆菌15份,保加利亚乳杆菌15份,嗜酸乳杆菌10份,干酪乳杆菌8份,嗜热链球菌8份,酿酒酵母8份,产朊假丝酵母菌4份;The probiotic powder is uniformly mixed with the following powders by weight: 40 parts of Lactobacillus plantarum, 30 parts of Bifidobacterium longum, 25 parts of Bifidobacterium bifidus, 15 parts of Bifidobacterium adolescentis, 15 parts of Lactobacillus bulgaricus , 10 parts of Lactobacillus acidophilus, 8 parts of Lactobacillus casei, 8 parts of Streptococcus thermophilus, 8 parts of Saccharomyces cerevisiae, 4 parts of Candida utilis;
所述益生菌粉剂益生菌活菌含量为:7x1012cfu/g;The probiotic live bacteria content of the probiotic powder is: 7× 10 12 cfu/g;
制备方法,包括如下步骤:The preparation method comprises the steps of:
1)按照配方比例,分别取D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、牛奶香精粉碎,过60目筛,然后混合3min,得混合粉;1) Take D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharides, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, The milk essence is crushed, passed through a 60-mesh sieve, and then mixed for 3 minutes to obtain a mixed powder;
2)将果胶分解物、柠檬酸、β-胡萝卜素溶于水中制成13%的水溶液,作为粘合剂;2) dissolving pectin decomposition products, citric acid, and β-carotene in water to make a 13% aqueous solution as a binder;
3)向所述混合粉中加入所述粘合剂制成软材,用10目筛制粒,得湿颗粒,置微波干燥机中于功率3000W、频率2450MHz、温度55℃干燥3min,用10目筛快速整粒;3) Add the binder to the mixed powder to make a soft material, granulate with a 10-mesh sieve to obtain wet granules, and dry them in a microwave dryer at a power of 3000W, a frequency of 2450MHz, and a temperature of 55°C for 3min, and use 10 Mesh sieve fast granulation;
4)将改性膳食纤维、α-环状糊精和益生菌粉混合5min,得包埋益生菌粉剂;4) Mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 5 minutes to obtain the embedded probiotic powder;
5)整好的颗粒与包埋益生菌粉剂、硬脂酸镁混合5min,混合均匀后,压片、包装即得保健食品片剂。5) Mix the prepared granules with the embedded probiotic powder and magnesium stearate for 5 minutes, and after mixing evenly, press into tablets and pack to obtain health food tablets.
实施例4Example 4
一种可改善肠道菌群的保健食品胶囊剂,由以下重量份数的原料制备:A health food capsule capable of improving intestinal flora, prepared from the following raw materials in parts by weight:
D-甘露糖醇35份,麦芽糊精20份,微晶纤维素20份,益生菌粉剂20份,改性膳食纤维12份,低聚木糖11份,异麦芽酮糖醇11份,浓缩乳清蛋白11份,食用菌提取物10份,雪莲培养物提取物8份,果胶分解物7份,α-环状糊精5份,柠檬酸2.5份,硬脂酸镁2.5份,牛奶香精2.5份,β-胡萝卜素2份;35 parts of D-mannitol, 20 parts of maltodextrin, 20 parts of microcrystalline cellulose, 20 parts of probiotic powder, 12 parts of modified dietary fiber, 11 parts of xylooligosaccharide, 11 parts of isomalt, concentrated 11 parts of whey protein, 10 parts of edible mushroom extract, 8 parts of snow lotus culture extract, 7 parts of pectin decomposition product, 5 parts of α-cyclodextrin, 2.5 parts of citric acid, 2.5 parts of magnesium stearate, milk 2.5 parts of essence, 2 parts of β-carotene;
所述益生菌粉剂由以下重量份数的粉剂均匀混合而成:植物乳杆菌50份,长双歧杆菌45份,两岐双岐杆菌35份,青春双岐杆菌20份,保加利亚乳杆菌20份,嗜酸乳杆菌15份,干酪乳杆菌10份,嗜热链球菌10份,酿酒酵母10份,产朊假丝酵母菌6份;The probiotic powder is uniformly mixed with the following powders by weight: 50 parts of Lactobacillus plantarum, 45 parts of Bifidobacterium longum, 35 parts of Bifidobacterium bifidum, 20 parts of Bifidobacterium adolescent, 20 parts of Lactobacillus bulgaricus , 15 parts of Lactobacillus acidophilus, 10 parts of Lactobacillus casei, 10 parts of Streptococcus thermophilus, 10 parts of Saccharomyces cerevisiae, 6 parts of Candida utilis;
所述益生菌粉剂益生菌活菌含量为:8x1012cfu/g;The probiotic live bacteria content of the probiotic powder is: 8× 10 12 cfu/g;
制备方法,包括如下步骤:The preparation method comprises the steps of:
1)按照配方比例,分别取D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、牛奶香精粉碎,过80目筛,然后混合10min,得混合粉;1) Take D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharides, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, The milk essence is crushed, passed through an 80-mesh sieve, and then mixed for 10 minutes to obtain a mixed powder;
2)将果胶分解物、柠檬酸、β-胡萝卜素溶于水中制成15%的水溶液,作为粘合剂;2) dissolving pectin decomposition products, citric acid, and β-carotene in water to make a 15% aqueous solution as a binder;
3)向所述混合粉中加入所述粘合剂制成软材,用16目筛制粒,得湿颗粒,置微波干燥机中于功率3000W、频率2450MHz、温度60℃干燥5min,用16目筛快速整粒;3) Add the binder to the mixed powder to make a soft material, granulate with a 16-mesh sieve to obtain wet granules, and dry them in a microwave dryer at a power of 3000W, a frequency of 2450MHz, and a temperature of 60°C for 5min, and use 16 Mesh sieve fast granulation;
4)将改性膳食纤维、α-环状糊精和益生菌粉混合8min,得包埋益生菌粉剂;4) Mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 8 minutes to obtain the embedded probiotic powder;
5)整好的颗粒与包埋益生菌粉剂、硬脂酸镁混合8min,混合均匀后,装粒,选囊,抛光,制成保健食品胶囊剂。5) The prepared granules are mixed with the embedded probiotic powder and magnesium stearate for 8 minutes, and after mixing evenly, they are loaded into granules, selected into capsules, polished, and made into health food capsules.
实施例5Example 5
一种可改善肠道菌群的保健食品颗粒剂,由以下重量份数的原料制备:A health food granule capable of improving intestinal flora, prepared from the following raw materials in parts by weight:
D-甘露糖醇5份,麦芽糊精5份,微晶纤维素5份,益生菌粉剂5份,改性膳食纤维5份,低聚木糖3份,异麦芽酮糖醇3份,浓缩乳清蛋白3份,食用菌提取物2份,雪莲培养物提取物3份,果胶分解物2份,α-环状糊精1份,柠檬酸0.1份,硬脂酸镁0.1份,牛奶香精0.1份,β-胡萝卜素0.01份;5 parts of D-mannitol, 5 parts of maltodextrin, 5 parts of microcrystalline cellulose, 5 parts of probiotic powder, 5 parts of modified dietary fiber, 3 parts of xylooligosaccharide, 3 parts of isomalt, concentrated 3 parts of whey protein, 2 parts of edible mushroom extract, 3 parts of snow lotus culture extract, 2 parts of pectin decomposition product, 1 part of α-cyclodextrin, 0.1 part of citric acid, 0.1 part of magnesium stearate, milk 0.1 part of essence, 0.01 part of β-carotene;
所述益生菌粉剂由以下重量份数的粉剂均匀混合而成:植物乳杆菌45份,长双歧杆菌38份,两岐双岐杆菌30份,青春双岐杆菌18份,保加利亚乳杆菌18份,嗜酸乳杆菌12份,干酪乳杆菌9份,嗜热链球菌9份,酿酒酵母9份,产朊假丝酵母菌5份;The probiotic powder is uniformly mixed with the following powders by weight: 45 parts of Lactobacillus plantarum, 38 parts of Bifidobacterium longum, 30 parts of Bifidobacterium bifidus, 18 parts of Bifidobacterium adolescent, and 18 parts of Lactobacillus bulgaricus , 12 parts of Lactobacillus acidophilus, 9 parts of Lactobacillus casei, 9 parts of Streptococcus thermophilus, 9 parts of Saccharomyces cerevisiae, 5 parts of Candida utilis;
所述益生菌粉剂益生菌活菌含量为:9x1012cfu/g;The probiotic live bacteria content of the probiotic powder is: 9× 10 12 cfu/g;
制备方法,包括如下步骤:The preparation method comprises the steps of:
1)按照配方比例,分别取D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、牛奶香精粉碎,过80目筛,然后混合10min,得混合粉;1) Take D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharides, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, The milk essence is crushed, passed through an 80-mesh sieve, and then mixed for 10 minutes to obtain a mixed powder;
2)将果胶分解物、柠檬酸、β-胡萝卜素溶于水中制成15%的水溶液,作为粘合剂;2) dissolving pectin decomposition products, citric acid, and β-carotene in water to make a 15% aqueous solution as a binder;
3)向所述混合粉中加入所述粘合剂制成软材,用16目筛制粒,得湿颗粒,置微波干燥机中于功率3000W、频率2450MHz、温度60℃干燥5min,用16目筛快速整粒;3) Add the binder to the mixed powder to make a soft material, granulate with a 16-mesh sieve to obtain wet granules, and dry them in a microwave dryer at a power of 3000W, a frequency of 2450MHz, and a temperature of 60°C for 5min, and use 16 Mesh sieve fast granulation;
4)将改性膳食纤维、α-环状糊精和益生菌粉混合8min,得包埋益生菌粉剂;4) Mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 8 minutes to obtain the embedded probiotic powder;
5)整好的颗粒与包埋益生菌粉剂、硬脂酸镁混合8min,混合均匀后,装袋、密封即得保健食品颗粒剂。5) The prepared granules are mixed with embedded probiotic powder and magnesium stearate for 8 minutes, and after mixing evenly, bagged and sealed to obtain health food granules.
实施例6Example 6
一种可改善肠道菌群的保健食品粉剂,由以下重量份数的原料制备:A health food powder capable of improving intestinal flora, prepared from the following raw materials in parts by weight:
D-甘露糖醇50份,麦芽糊精30份,微晶纤维素30份,益生菌粉剂30份,改性膳食纤维20份,低聚木糖15份,异麦芽酮糖醇15份,浓缩乳清蛋白15份,食用菌提取物12份,雪莲培养物提取物10份,果胶分解物10份,α-环状糊精10份,柠檬酸3份,硬脂酸镁3份,牛奶香精3份,β-胡萝卜素3份;50 parts of D-mannitol, 30 parts of maltodextrin, 30 parts of microcrystalline cellulose, 30 parts of probiotic powder, 20 parts of modified dietary fiber, 15 parts of xylooligosaccharide, 15 parts of isomalt, concentrated 15 parts of whey protein, 12 parts of edible mushroom extract, 10 parts of snow lotus culture extract, 10 parts of pectin decomposition product, 10 parts of α-cyclodextrin, 3 parts of citric acid, 3 parts of magnesium stearate, milk 3 parts of essence, 3 parts of β-carotene;
所述益生菌粉剂由以下重量份数的粉剂均匀混合而成:植物乳杆菌45份,长双歧杆菌38份,两岐双岐杆菌30份,青春双岐杆菌18份,保加利亚乳杆菌18份,嗜酸乳杆菌12份,干酪乳杆菌9份,嗜热链球菌9份,酿酒酵母9份,产朊假丝酵母菌5份;The probiotic powder is uniformly mixed with the following powders by weight: 45 parts of Lactobacillus plantarum, 38 parts of Bifidobacterium longum, 30 parts of Bifidobacterium bifidus, 18 parts of Bifidobacterium adolescent, and 18 parts of Lactobacillus bulgaricus , 12 parts of Lactobacillus acidophilus, 9 parts of Lactobacillus casei, 9 parts of Streptococcus thermophilus, 9 parts of Saccharomyces cerevisiae, 5 parts of Candida utilis;
所述益生菌粉剂益生菌活菌含量为:9x1012cfu/g;The probiotic live bacteria content of the probiotic powder is: 9× 10 12 cfu/g;
制备方法,包括如下步骤:The preparation method comprises the steps of:
1)按配方比例,将改性膳食纤维、α-环状糊精和益生菌粉混合8min,得包埋益生菌粉剂;1) According to the formula ratio, mix the modified dietary fiber, α-cyclodextrin and probiotic powder for 8 minutes to obtain the embedded probiotic powder;
2)按照配方比例,将D-甘露糖醇、麦芽糊精、微晶纤维素、低聚木糖、异麦芽酮糖醇、浓缩乳清蛋白、食用菌提取物、雪莲培养物提取物、果胶分解物、柠檬酸粉碎,过100目筛,然后与包埋益生菌粉剂、β-胡萝卜素、牛奶香精、硬脂酸镁混合8min即得保健食品粉剂。2) According to the formula ratio, D-mannitol, maltodextrin, microcrystalline cellulose, xylooligosaccharide, isomalt, whey protein concentrate, edible fungus extract, snow lotus culture extract, fruit Gum decomposition products and citric acid were pulverized, passed through a 100-mesh sieve, and then mixed with embedded probiotic powder, β-carotene, milk essence, and magnesium stearate for 8 minutes to obtain a health food powder.
实施例7本发明可改善肠道菌群的保健食品的感官品评试验Example 7 The present invention can improve the sensory evaluation test of the health food of intestinal flora
邀请24名人员对本发明实施例2-6制备的保健食品与市售两种含益生菌的保健食品进行品评,感官打分,其中专业和非专业人员各12名,专业人员青年、中年、老年各4名,男女各半,非专业人员少年、青年、中年、老年各3名,男女各半;打分包括外观(20分)、质地(25分)、风味(30分)、口感(25分)四个方面,打分人员独立进行,互不影响,以保证品评结果准确。对品评结果进行了统计,均分值取近似值,保留整数,具体见表1:Invite 24 persons to evaluate the health food prepared by Examples 2-6 of the present invention and two kinds of health food containing probiotics on the market, and make sensory scores, including 12 professionals and 12 non-professionals, professional young, middle-aged and old 4 each, half male and half male, three non-professional teenagers, youth, middle-aged, and elderly, half male and half male; scoring includes appearance (20 points), texture (25 points), flavor (30 points), taste (25 points) Scoring) The four aspects are conducted independently by the scoring personnel without affecting each other, so as to ensure the accuracy of the evaluation results. The evaluation results were counted, and the average score was approximated, and integers were reserved. See Table 1 for details:
表1 感官品评统计结果Table 1 Statistical results of sensory evaluation
注:同一行内标不同小写字母表示差异显著(P<0.05),标不同大写字母表示差异极显著(P<0.01),标有相同字母表示差异不显著(P>0.05)。Note: Different lowercase letters in the same row indicate significant differences (P<0.05), different uppercase letters indicate extremely significant differences (P<0.01), and the same letters indicate no significant differences (P>0.05).
以上结果表明,本发明制备的保健食品从外观、质地、风味和口感任何一方面都要明显优于市售市售含益生菌的保健食品,特别是风味极好,同时也适合不同年龄段、不同消费层次的消费者食用。The above results show that the health food prepared by the present invention is obviously better than the health food containing probiotics on the market in terms of appearance, texture, flavor and mouthfeel, especially the flavor is excellent, and it is also suitable for different age groups, Consumers of different consumption levels eat.
实施例8本发明可改善肠道菌群的保健食品的益生性试验Example 8 The present invention can improve the probiotic test of the health food of intestinal flora
将本发明实施例2制备的保健食品片剂,用无菌水制备成活菌数为2×1010CFU/mL的益生菌溶液,于4℃保存备用;The health food tablet prepared in Example 2 of the present invention was prepared into a probiotic solution with a viable count of 2×10 10 CFU/mL with sterile water, and stored at 4°C for later use;
1、取保存好的10mL益生菌溶液注入到试管1中,采用十倍逐级稀释至10-8,取1mL稀释液在平板上,将灭菌后冷却至45℃的MRS琼脂培养基倾注在平板(灭菌)上,迅速摇匀。再将装有10mL益生菌溶液的试管2置于80-90℃水浴锅中加热15-25min,取加热后的益生菌溶液进行十倍逐级稀释至10-8,取1mL稀释液在平板上,将灭菌后冷却至45℃的MRS琼脂培养基倾注在平板(灭菌)上并迅速摇匀。最后将加热前和加热后的平板均在35℃条件下培养24h,计算加热前后的数量。1. Take 10mL of the preserved probiotic solution and pour it into test tube 1, dilute it to 10-8 by ten times, take 1mL of the diluted solution on the plate, and pour the sterilized MRS agar medium cooled to 45°C on the Plate (sterilized), shake quickly. Then put the test tube 2 containing 10mL of probiotic solution in a water bath at 80-90°C and heat it for 15-25min, take the heated probiotic solution and dilute it tenfold to 10 -8 step by step, and take 1mL of the diluted solution on the plate , Pour the sterilized MRS agar medium cooled to 45°C on the plate (sterilized) and shake it up quickly. Finally, the plates before and after heating were incubated at 35° C. for 24 hours, and the numbers before and after heating were calculated.
结果表明,活菌存活率达到了88%。The results showed that the survival rate of live bacteria reached 88%.
2、模拟胃液及肠液的耐受试验:取100g/L的盐酸16.4mL加蒸馏水稀释,使pH值分别为1.5、2.5和3.5,取100mL稀盐酸溶液,分别加入1g胃蛋白酶,使其充分溶解,得模拟胃液,微孔滤膜除菌(0.22μm)备用。取磷酸二氢钾6.8g,加水500mL使溶解,用0.1moL/L氢氧化钠溶液调节pH值至6.8;另取胰蛋白酶10g,加水100mL使溶解,将两液混合后,加水稀释至1000ml,得模拟肠液,微孔滤膜除菌(0.22μm)备用。取1mL保存好的益生菌溶液加入到9mL的模拟胃液中(即十倍逐级稀释),并迅速在振荡器上充分混匀,然后置于30-45℃静置培养2-4h。分别在1h、2h、3h、4h的时候取出培养液并立即计数残存活菌数,与原活菌数进行比较,结果表明,活菌存活率为97%。然后取在人工胃液中消化不同时间的培养液各1mL,分别接种于9mL pH值为6.8的人工肠液中,置于30-45℃静置培养2-4h,并分别在0、3、6、24h取样,测定其活菌数,与原活菌数进行比较,结果表明活菌存活率为99%。2. Tolerance test of simulated gastric juice and intestinal juice: take 16.4mL of 100g/L hydrochloric acid and distill it with distilled water to make the pH values respectively 1.5, 2.5 and 3.5, take 100mL of dilute hydrochloric acid solution, add 1g of pepsin respectively, and make it fully dissolved , to obtain simulated gastric juice, which was sterilized by a microporous membrane filter (0.22 μm) for later use. Take 6.8g of potassium dihydrogen phosphate, add 500mL of water to dissolve, adjust the pH value to 6.8 with 0.1moL/L sodium hydroxide solution; take another 10g of trypsin, add 100mL of water to dissolve, mix the two liquids, add water to dilute to 1000ml, The simulated intestinal fluid was obtained and sterilized by a microporous membrane filter (0.22 μm) for later use. Take 1mL of the preserved probiotic solution and add it to 9mL of simulated gastric juice (that is, ten-fold serial dilution), and quickly mix well on a shaker, and then place it at 30-45°C for static incubation for 2-4h. The culture solution was taken out at 1h, 2h, 3h, and 4h respectively, and the number of residual viable bacteria was counted immediately, compared with the original number of viable bacteria. The results showed that the survival rate of viable bacteria was 97%. Then take 1mL of the culture solution digested in artificial gastric juice for different times, inoculate them in 9mL of artificial intestinal juice with a pH value of 6.8, place them at 30-45°C for 2-4h, and incubate at 0, 3, 6, Take samples at 24 hours, measure the number of live bacteria, and compare with the original number of live bacteria. The result shows that the survival rate of live bacteria is 99%.
3、模拟胆盐的耐受试验:用胰液素制成1g/L的溶液,并在溶液中加入0.8%的猪胆盐,用10%的NaOH调整pH为8.0,然后用0.45μm微滤膜过滤并除菌。将0.5mL保存好的益生菌溶液接种到4.5mL模拟胆盐中,培养24h后得到培养液,计数残存的活菌数。将培养液在灭菌生理盐水中十倍逐级稀释至10-8,并用MRS倾注,然后置于35℃静置培养24h。结果表明活菌存活率为99%。3. Tolerance test of simulated bile salts: use pancreatin to make a 1g/L solution, add 0.8% porcine bile salts to the solution, adjust the pH to 8.0 with 10% NaOH, and then use a 0.45 μm microfiltration membrane Filter and sterilize. Inoculate 0.5mL of the preserved probiotic solution into 4.5mL of simulated bile salts, cultivate for 24 hours to obtain a culture solution, and count the number of remaining viable bacteria. The culture solution was diluted tenfold in sterilized saline to 10 -8 , poured with MRS, and then cultured at 35° C. for 24 hours. The results showed that the survival rate of live bacteria was 99%.
以上试验结果表明,本发明保健食品中的益生菌益生性(耐热性、耐pH性、耐胆盐)较强,非常适合人体胃肠环境,在模拟胃肠环境中存活率大,可有效改善胃肠功能。The above test results show that the probiotics in the health food of the present invention have strong probiotic properties (heat resistance, pH resistance, bile salt resistance), are very suitable for the human gastrointestinal environment, have a large survival rate in the simulated gastrointestinal environment, and can effectively Improve gastrointestinal function.
需要说明的是:本发明实施例3-6制备的保健食品同样具有上述实验效果,各实施例之间及与上述实验效果差异性不大。It should be noted that the health foods prepared in Examples 3-6 of the present invention also have the above-mentioned experimental effects, and there is little difference between each embodiment and the above-mentioned experimental effects.
实施例9保健食品小鼠肠道性能试验Example 9 Health Food Mice Intestinal Performance Test
将本发明实施例2制备的保健食品片剂,用无菌水制备成活菌数为2×1010CFU/mL的益生菌溶液,于4℃保存备用;The health food tablet prepared in Example 2 of the present invention was prepared into a probiotic solution with a viable count of 2×10 10 CFU/mL with sterile water, and stored at 4°C for later use;
选取普通昆明小白鼠60只,雌雄各半,18-20g,常规词养。从中随机挑选40只,每天早晨9:00灌胃盐酸林可霉素0.2mL(20mg)/只,其它作为对照组,每天同一时间灌胃等量灭菌生理盐水,连续一周,制备肠道菌群失调的小鼠模型。模型组小鼠饮食下降,未出现死亡和明显的腹泻现象,排软粪,外形正常含水分较多,垫料潮湿。将40只肠道菌群失调小鼠,随机分为2组,一组20只作为治疗组,每天灌胃保存好的益生菌溶液0.5ml(2×1010cfu/ml)/只,另20只作为自然恢复组,每天同一时间灌胃等量灭菌生理盐水,连续两周。整个试验期21天,每天观察小白鼠的生长和排便情况,于第8、21天对益生菌片剂治疗组和自然恢复组的小鼠进行称重,计算各组体重平均增长率,结果如表1;每5天测各组小鼠粪便大肠杆菌数量,计算平均数,结果如表2。取小鼠粪便约0.1g,于无菌操作台内加入3粒玻璃珠(以0.1g粪样加0.5mL稀释液),稀释并接种麦康凯琼脂培养基,计算每克湿便中的大肠杆菌数。Select 60 ordinary Kunming mice, half male and half male, weighing 18-20 g, and raise them conventionally. Randomly select 40 of them, and administrate lincomycin hydrochloride 0.2mL (20mg) per animal at 9:00 every morning. A mouse model of group dysbiosis. The diet of the mice in the model group decreased, no death or obvious diarrhea occurred, the feces were soft, the appearance was normal, the water content was high, and the litter was wet. Forty mice with intestinal flora imbalance were randomly divided into 2 groups. A group of 20 mice was used as a treatment group, and 0.5ml (2×10 10 cfu/ml) of the preserved probiotic solution was administered orally every day, and the other 20 Only as the natural recovery group, the same amount of sterilized saline was administered to the rats at the same time every day for two consecutive weeks. During the whole test period of 21 days, the growth and defecation of the mice were observed every day, and the mice in the probiotic tablet treatment group and the natural recovery group were weighed on the 8th and 21st days, and the average growth rate of body weight in each group was calculated. The results are as follows: Table 1; The number of Escherichia coli in the feces of mice in each group was measured every 5 days, and the average number was calculated. The results are shown in Table 2. Take about 0.1g of mouse feces, add 3 glass beads (add 0.5mL diluent to 0.1g feces sample) in a sterile operating table, dilute and inoculate MacConkey agar medium, and calculate the Escherichia coli per gram of wet feces number.
表2 小鼠增重情况Table 2 Weight gain of mice
表3 小鼠粪便中大肠杆菌数的情况Table 3 The number of Escherichia coli in mouse feces
保健食品治疗组小鼠体重平均增长率(59.63%)显著高于自然恢复组(32.14%);饲喂溶液后肠道大肠杆菌数量显著下降,降低82.62%,显著低于自然恢复组(24.78%),表明本发明保健食品片剂中的益生菌在小白鼠肠道内迅速定植,形成优势菌群,并有效抑制大肠杆菌等病原菌的生长繁殖,并且定植时间长,持续、有效改善了肠道性能。The average growth rate of body weight (59.63%) of the mice in the health food treatment group was significantly higher than that of the natural recovery group (32.14%); the number of intestinal E. ), it shows that the probiotics in the health food tablet of the present invention colonize rapidly in the intestinal tract of mice, form dominant flora, and effectively inhibit the growth and reproduction of pathogenic bacteria such as Escherichia coli, and the colonization time is long, continuously and effectively improving intestinal performance .
需要说明的是:本发明实施例3-6制备的保健食品同样具有上述实验效果,各实施例之间及与上述实验效果差异性不大。It should be noted that the health foods prepared in Examples 3-6 of the present invention also have the above-mentioned experimental effects, and there is little difference between each embodiment and the above-mentioned experimental effects.
实施例10本发明保健食品对机体免疫力的影响Embodiment 10 The influence of health food of the present invention on body immunity
1实验目的1 Experiment purpose
通过运动耐力测试(小鼠游泳试验),验证本发明保健食品的提高免疫力、抗疲劳作用。Through the exercise endurance test (mouse swimming test), verify the effect of improving immunity and anti-fatigue of the health food of the present invention.
2实验材料与试剂2 Experimental materials and reagents
2.1供试药物:2.1 Test drug:
市售含益生菌的保健食品(G1);市售含益生菌的保健食品(G2);本发明实施例2-6制备的保健食品(G3-G7)。Commercially available health food (G1) containing probiotics; commercially available health food (G2) containing probiotics; health food (G3-G7) prepared in Examples 2-6 of the present invention.
2.2试剂:2.2 Reagents:
肝/肌糖原测试盒,购自南京建成生物制品研究所;浓硫酸(AR),南京化学试剂有限公司;生理盐水,山东长富洁晶药业有限公司。Liver/muscle glycogen test kits were purchased from Nanjing Jiancheng Institute of Biological Products; concentrated sulfuric acid (AR), Nanjing Chemical Reagent Co., Ltd.; normal saline, Shandong Changfu Jiejing Pharmaceutical Co., Ltd.
3.实验动物3. Experimental animals
ICR小鼠,♂,清洁级,体重18-22g,由扬州大学比较医学中心提供,合格证号:SCXK(苏)2007–0001,实验期间小鼠自由饮食。ICR mice, ♂, clean grade, weighing 18-22 g, were provided by the Comparative Medicine Center of Yangzhou University, certificate number: SCXK (Su) 2007-0001, and the mice were free to eat and drink during the experiment.
4.主要仪器4. Main instruments
铝制游泳箱(50cm×50cm×40cm),铅丝,低温高速离心机:5804R型,Eppendrof公司;水浴锅:DK-S26型,上海精宏实验设备有限公司;电子称:BS224S型,Sartorius公司;秒表,温度计Aluminum swimming box (50cm×50cm×40cm), lead wire, low-temperature high-speed centrifuge: 5804R type, Eppendrof company; water bath: DK-S26 type, Shanghai Jinghong Experimental Equipment Co., Ltd.; electronic name: BS224S type, Sartorius company; stopwatch, thermometer
5.实验分组5. Experimental grouping
5.1剂量分组及受试样品给予时间随机将小鼠分为8组,每组10只,第1组至第7组分别给G1~G7的药物,第8组为空白对照组,给予等体积的双蒸水,每组每日均灌胃1次,灌胃体积为0.2ml/10g,连续给予受试样品30天。5.1 Dose grouping and time of administration of test samples. The mice were randomly divided into 8 groups, 10 in each group. Groups 1 to 7 were given drugs from G1 to G7, and group 8 was the blank control group, which was given equal volume Double-distilled water was given to each group by intragastric administration once a day, with a volume of 0.2ml/10g, and the test samples were given continuously for 30 days.
5.2样品配制第1组至第7组:称取2.25g药物样品,用蒸馏水配至150ml;空白对照组:双蒸水150ml。5.2 Sample preparation Groups 1 to 7: Weigh 2.25g of drug samples and make up to 150ml with distilled water; blank control group: 150ml of double distilled water.
6.实验方法6. Experimental method
6.1负重游泳实验末次给药30min后,置小鼠于游泳箱中,水深不少于30cm,水温25±1℃,鼠尾根部负荷5%体重的铅皮,记录小鼠游泳开始至死亡的时间,作为小鼠游泳时间。6.1 30 minutes after the last administration of the weight-bearing swimming test, put the mice in the swimming box, the water depth is not less than 30cm, the water temperature is 25±1°C, and the root of the tail of the mice is loaded with 5% lead skin of body weight, and the time from the start of swimming to the death of the mice is recorded , as mouse swimming time.
6.2小鼠血清尿素测定末次给药30min后,在温度为30℃的水中不负重游泳90min,休息60min后摘眼球采血0.5mL(不加抗凝剂),置4℃冰箱3h,血凝固后2000r/min离心15min,取血清送连云港市第一人民医院检验科检测。6.2 Determination of serum urea in mice After 30 minutes of the last administration, swim without weight in water at a temperature of 30°C for 90 minutes, rest for 60 minutes, and take 0.5mL of blood from the eye (without anticoagulant), put it in a refrigerator at 4°C for 3 hours, and 2000r after blood coagulation /min centrifuged for 15min, and the serum was taken and sent to the Laboratory Department of Lianyungang First People's Hospital for testing.
6.3肝糖原的测定末次给药30min后,在温度为25±1℃的水中不负重游泳90min,颈椎脱臼处死小鼠,用生理盐水洗净,并用滤纸吸干水分后,准确称取肝脏100mg,肝糖原检测试剂盒检测小鼠肝糖原含量。6.3 Determination of liver glycogen 30 minutes after the last administration, swim in water at a temperature of 25±1°C without weight for 90 minutes, kill the mice by cervical dislocation, wash with normal saline, dry the water with filter paper, and accurately weigh 100 mg of the liver , Liver glycogen detection kit to detect mouse liver glycogen content.
6.4血乳酸的测定末次给药30min后采血,然后不负重在温度为30℃的水中游泳10min后停止。乳酸仪测定方法:分别在游泳前、游泳后、游泳后休息20min后各采血20μL加入40μL破膜液中,立即充分振荡破碎细胞用乳酸仪测定。(血乳酸曲线下面积=5×(游泳前血乳酸值+3×游泳后0min的血乳酸值+2×游泳后20min的血乳酸值)6.4 Determination of blood lactic acid Blood was collected 30 minutes after the last administration, and then stopped swimming in water at a temperature of 30°C without weight for 10 minutes. Lactic acid meter measurement method: before swimming, after swimming, and after swimming for 20 minutes, 20 μL of blood was collected and added to 40 μL of permeabilization solution, and the cells were fully shaken and broken up immediately with a lactic acid meter for measurement. (Area under the blood lactic acid curve = 5 × (blood lactic acid value before swimming + 3 × blood lactic acid value at 0 min after swimming + 2 × blood lactic acid value at 20 min after swimming)
7.观察指标负重游泳时间,血乳酸、尿素、肝糖原值7. Observation indicators Weight-bearing swimming time, blood lactic acid, urea, liver glycogen value
8.统计方法实验数据用x±s表示,采用t检验进行组间比较8. Statistical method The experimental data is represented by x±s, and the t test is used for comparison between groups
9.实验结果9. Experimental results
9.1本发明保健食品对小鼠体重的影响9.1 Effect of health food of the present invention on mouse body weight
各组小鼠在给予G1~G7药物后,前、中,后期体重分别见下表所示,各组小鼠的初始体重和增重体重与对照组比较均无统计学差异(P>0.05),表明G1~G7药物均无明显的毒性。实验结果详见表4。After administration of G1~G7 drugs, the body weights of the mice in each group are shown in the table below. The initial body weight and weight gain of the mice in each group were not significantly different from those in the control group (P>0.05) , indicating that G1~G7 drugs have no obvious toxicity. The experimental results are shown in Table 4.
表4 负重游泳实验小鼠的初始体重、中期体重和结束体重 Table 4 Initial body weight, mid-term body weight and end body weight of mice in weight-bearing swimming experiment
9.2本发明保健食品对小鼠负重游泳时间的影响9.2 Effects of the health food of the present invention on the weight-bearing swimming time of mice
经口给予小鼠G1~G7药物后,G1~G2药物与空白对照组比较,可以明显延长小鼠负重游泳时间,具有显著性差异(P<0.05),本发明保健食品G3~G7药物与空白对照组比较,可以显著延长小鼠负重游泳时间,具有极显著性差异(P<0.01),且明显优于G1~G2药物。结果详见表5。After oral administration of G1~G7 medicines to mice, G1~G2 medicines can significantly prolong the weight-bearing swimming time of mice compared with the blank control group, and there is a significant difference (P<0.05). Compared with the control group, it can significantly prolong the weight-bearing swimming time of mice, with a very significant difference (P<0.01), and it is obviously better than G1-G2 drugs. The results are detailed in Table 5.
表5 本发明保健食品对小鼠负重游泳时间的影响 Table 5 The impact of health food of the present invention on the weight-bearing swimming time of mice
“*”p<0.05vs空白对照;"*"p<0.05vs blank control;
“**”p<0.01vs空白对照;"**"p<0.01vs blank control;
9.3本发明保健食品对小鼠运动前后血乳酸的影响9.3 Effect of health food of the present invention on blood lactic acid in mice before and after exercise
经口给予小鼠本发明保健食品后,本发明保健食品G3~G7药物对小鼠运动后血乳酸曲线下面积与对照组比较有统计学差异(P<0.05),G1~G2药物组小鼠血乳酸曲线下面积与对照组比较虽有所降低,但并无统计学差异(P>0.05)。结果见表6。After oral administration of the health food of the present invention to mice, the health food G3~G7 medicine of the present invention has a statistical difference (P<0.05) on the area under the curve of the blood lactic acid of the mice after exercise compared with the control group (P<0.05), and the mice in the G1~G2 medicine group Compared with the control group, the area under the curve of blood lactic acid decreased, but there was no statistical difference (P>0.05). The results are shown in Table 6.
表6 本发明保健食品对小鼠运动前后血乳酸水平的影响 Table 6 Effect of health food of the present invention on blood lactic acid level of mice before and after exercise
“*”p<0.05vs空白对照;"*"p<0.05vs blank control;
9.4本发明保健食品对小鼠肝糖原的影响9.4 Effect of health food of the present invention on mouse liver glycogen
经口给予小鼠G1~G7药物后,G1~G2药物与空白对照组比较,小鼠肝糖原含量均有明显的升高,具有显著性差异(P<0.05),本发明保健食品G3~G7药物与与空白对照组比较,小鼠肝糖原含量均有明显的升高,具有极显著性差异(P<0.01),且明显优于G1~G2药物。结果详见表7。After oral administration of G1~G7 medicines to mice, G1~G2 medicines were compared with the blank control group, and the mouse liver glycogen content all had a significant increase (P<0.05). The health food G3~ Compared with the blank control group, the G7 drug significantly increased the liver glycogen content of the mice, with a very significant difference (P<0.01), and it was significantly better than the G1-G2 drugs. The results are detailed in Table 7.
表7 本发明保健食品对小鼠肝糖原含量的影响 Table 7 Effect of health food of the present invention on mouse liver glycogen content
“*”p<0.05vs空白对照;"*"p<0.05vs blank control;
“**”p<0.01vs空白对照;"**"p<0.01vs blank control;
9.5本发明保健食品对小鼠血清尿素的影响9.5 Effect of health food of the present invention on mouse serum urea
经口给予小鼠G1~G7药物后,G1~G2药物组与空白对照组比较,小鼠运动后血清尿素含量均有明显的降低,具有显著性差异(P<0.05),本发明保健食品G3~G7药物与与空白对照组比较,小鼠运动后血清尿素含量均有明显的降低均有明显的降低,具有极显著性差异(P<0.01),且明显优于G1~G2药物。结果详见表8。After oral administration of G1~G7 drugs to mice, the G1~G2 drug groups were compared with the blank control group, and the serum urea content of the mice after exercise was significantly reduced (P<0.05). The health food G3 of the present invention Compared with the blank control group, the ~G7 drug has a significant decrease in the serum urea content after exercise, with a very significant difference (P<0.01), and it is significantly better than the G1~G2 drug. The results are detailed in Table 8.
表8 本发明保健食品对小鼠血清尿素含量的影响 Table 8 Effect of health food of the present invention on mouse serum urea content
“*”p<0.05vs空白对照;"*"p<0.05vs blank control;
“**”p<0.01vs空白对照;"**"p<0.01vs blank control;
10.实验结论10. Experimental conclusion
本实验主要通过小鼠负重游泳实验,同时检测小鼠肝糖原的储备来观察本发明保健食品的提高免疫力、抗疲劳效果。初步研究结果显示如下:This experiment mainly observes the effect of improving immunity and anti-fatigue of the health food of the present invention through the weight-bearing swimming test of mice and detecting the reserve of mouse liver glycogen. Preliminary research results show the following:
1、本发明G3~G7保健食品均能延长小鼠负重游泳时间(P<0.01),且效果明显优于其它G1~G2的市售保健食品。1. The G3-G7 health food of the present invention can prolong the weight-bearing swimming time of mice (P<0.01), and the effect is obviously better than other G1-G2 health food in the market.
2、生化检测方面显示,本发明G3~G7保健食品各剂量组均能减少运动后小鼠血清中葡萄糖无氧酵解所产生的乳酸含量,与对照组比较有显著性差异(P<0.05),而其它G1~G2的市售保健食品虽然也能减少运动后小鼠血清中葡萄糖无氧酵解所产生的乳酸含量,但与对照组比较,无统计学差异(P>0.05);2. Biochemical testing shows that each dose group of G3~G7 health food of the present invention can reduce the lactic acid content produced by anaerobic glycolysis of glucose in mouse serum after exercise, and there is a significant difference compared with the control group (P<0.05) , while other G1-G2 commercially available health foods can also reduce the lactic acid content produced by anaerobic glycolysis of glucose in serum of mice after exercise, but compared with the control group, there is no statistical difference (P>0.05);
3、本发明G3~G7保健食品各剂量组均能显著提高小鼠肝脏中糖原的储备(P<0.01),且效果明显优于其它G1~G2的市售保健食品;3. Each dosage group of G3-G7 health food of the present invention can significantly increase the storage of glycogen in the mouse liver (P<0.01), and the effect is obviously better than other G1-G2 commercially available health food;
4、高尿酸模型发现,本发明G3~G7保健食品能显著降低小鼠游泳后血清中尿素的含量(P<0.01),且效果明显优于其它G1~G2市售保健食品;4. It was found in the high uric acid model that the G3-G7 health food of the present invention can significantly reduce the content of urea in the serum of mice after swimming (P<0.01), and the effect is obviously better than other G1-G2 commercially available health food;
11.结论11. Conclusion
上述实验证明本发明保健食品能显著提高机体免疫力,提高小鼠的体力和耐力,降低小鼠运动后血清中尿素及乳酸的含量,且能显著提高小鼠肝脏中糖原的储备,有助于缓解运动负荷引起的疲劳;能延长小鼠负重游泳至力竭的时间。The above experiments prove that the health food of the present invention can significantly improve the immunity of the body, improve the physical strength and endurance of the mice, reduce the content of urea and lactic acid in the serum of the mice after exercise, and can significantly increase the storage of glycogen in the liver of the mice, which helps It is used to relieve fatigue caused by exercise load; it can prolong the time for mice to swim with weight to exhaustion.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510033640.7A CN104544086B (en) | 2015-01-23 | 2015-01-23 | A health food capable of improving intestinal flora and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510033640.7A CN104544086B (en) | 2015-01-23 | 2015-01-23 | A health food capable of improving intestinal flora and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104544086A CN104544086A (en) | 2015-04-29 |
CN104544086B true CN104544086B (en) | 2016-10-05 |
Family
ID=53062008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510033640.7A Expired - Fee Related CN104544086B (en) | 2015-01-23 | 2015-01-23 | A health food capable of improving intestinal flora and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104544086B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109718256A (en) * | 2018-12-14 | 2019-05-07 | 浙江九如堂生物科技有限公司 | For improving the unbalance composition and its preparation method and application of intestinal flora |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105076439A (en) * | 2015-07-16 | 2015-11-25 | 北京市绿友食品有限公司 | Fruit puree and yogurt freeze-dried tablet and preparation method thereof |
CN104982526A (en) * | 2015-07-28 | 2015-10-21 | 天津天绿健科技有限公司 | Yoghourt slice and preparation method thereof |
CN105028638A (en) * | 2015-07-28 | 2015-11-11 | 邵素英 | Fruit and vegetable lactic acid bacteria tablet and preparation method thereof |
CN105028637A (en) * | 2015-07-28 | 2015-11-11 | 邵素英 | Fruit puree tablet containing probiotics and preparation method for fruit puree tablet |
CN105124549B (en) * | 2015-07-29 | 2018-08-21 | 广州金酮特殊医用食品有限公司 | A kind of alimentation composition and preparation method thereof reducing radiation hazradial bundle |
CN105595313A (en) * | 2015-12-17 | 2016-05-25 | 范健身 | Bifidobacterium composition for enhancing immunity |
CN105661520A (en) * | 2016-01-29 | 2016-06-15 | 东莞市东卓中天生物科技有限公司 | Food for regulating intestinal tract and preparation method of food |
CN105685970A (en) * | 2016-02-01 | 2016-06-22 | 北京东方兴企食品工业技术有限公司 | Compound nutritious food capable of improving whole digestive tract |
CN105639655A (en) * | 2016-02-26 | 2016-06-08 | 暨南大学 | Health care product capable of promoting proliferation of intestinal bifidobacteria and application |
CN106616171A (en) * | 2016-09-18 | 2017-05-10 | 大连普瑞康生物技术有限公司 | Probiotic beverage containing saussurea involucrate culture and preparation method thereof |
KR101765559B1 (en) * | 2016-09-27 | 2017-08-07 | 이대희 | Probiotics composition containing hericium erinaceus |
CN106579219A (en) * | 2016-12-19 | 2017-04-26 | 罗城仫佬族自治县金陆地种养农民专业合作社 | Crataegus pinnatifida jelly capable of invigorating stomach and promoting digestion and preparation method of crataegus pinnatifida jelly |
CN107057908A (en) * | 2017-06-15 | 2017-08-18 | 蔡敬侠 | It is a kind of that there is the health liquor and its brewing method for improving human body stomach |
CN107557308A (en) * | 2017-09-11 | 2018-01-09 | 梁世高 | A kind of saccharomycete and its compound from slop extraction |
CN107927792A (en) * | 2017-11-08 | 2018-04-20 | 苏州健世星生物科技有限公司 | It is a kind of to utilize radix bardanae dry powder and milk powder embedding, the method for production probiotic powder |
CN107751703A (en) * | 2017-11-28 | 2018-03-06 | 广东君道营养科技有限公司 | A kind of solid beverage and its detection method with regulation gut flora function |
CN109549197A (en) * | 2018-10-16 | 2019-04-02 | 济南瑞丰生物工程有限公司 | A kind of enzymatic is total to the preparation method of ferment spy doctor's food with microorganism |
PH12021552307A1 (en) * | 2019-03-29 | 2022-07-04 | Asahi Group Holdings Ltd | Athletic ability enhancing composition |
CN110075281A (en) * | 2019-04-26 | 2019-08-02 | 青岛农业大学 | A kind of enhancing the anti-oxidant of pet, intestinal flora and composition of immunity and preparation method thereof |
CN110024932A (en) * | 2019-04-29 | 2019-07-19 | 哈尔滨求真生物科技有限公司 | A kind of black fungus extract solid drink formula and preparation method thereof for losing weight, improving diarrhea, adjust flora |
CN110393216A (en) * | 2019-08-13 | 2019-11-01 | 江苏安泰生物技术有限公司 | A kind of anti-helicobacter pylori health food and preparation method thereof |
CN111567796A (en) * | 2020-05-27 | 2020-08-25 | 山东探克生物科技股份有限公司 | Sports nutritional probiotic composition and preparation method thereof |
CN113142420B (en) * | 2020-09-17 | 2022-11-08 | 福建大北农水产科技有限公司 | Microecological preparation and fermentation method and application thereof |
CN112690336A (en) * | 2021-01-29 | 2021-04-23 | 刘刚 | Milk containing edible fungus polysaccharide extract and preparation method thereof |
CN114350589B (en) * | 2022-01-26 | 2023-07-04 | 光明乳业股份有限公司 | Microorganism proliferation agent, beverage and preparation method thereof |
CN114711435B (en) * | 2022-04-06 | 2023-05-09 | 深圳安馨堂生物科技有限公司 | Dietary fiber probiotic composition and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1545936A (en) * | 2003-12-01 | 2004-11-17 | 上海交大昂立股份有限公司 | Edible combination containing active Lactobacillus paracasei and preparation method thereof |
CN104095180A (en) * | 2013-04-12 | 2014-10-15 | 中国科学院烟台海岸带研究所 | Probiotics inulin sheet and preparation method thereof |
CN104082706A (en) * | 2014-06-11 | 2014-10-08 | 十堰伏龙山绿色食品开发有限公司 | Black fungus chewing tablets and preparation method thereof |
CN104509864B (en) * | 2015-01-20 | 2016-09-07 | 北京东方兴企食品工业技术有限公司 | A kind of have nutritional health food improving gastrointestinal function and preparation method thereof |
-
2015
- 2015-01-23 CN CN201510033640.7A patent/CN104544086B/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109718256A (en) * | 2018-12-14 | 2019-05-07 | 浙江九如堂生物科技有限公司 | For improving the unbalance composition and its preparation method and application of intestinal flora |
Also Published As
Publication number | Publication date |
---|---|
CN104544086A (en) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104544086B (en) | A health food capable of improving intestinal flora and preparation method thereof | |
CN104509864B (en) | A kind of have nutritional health food improving gastrointestinal function and preparation method thereof | |
CN105167072B (en) | A kind of production method of feature matrimony vine ferment and its product | |
CN105146614B (en) | A kind of functional calcium fruit ferment, enzyme beverage and its production method | |
CN104489646B (en) | A kind of fruit and vegerable probiotic tablet and preparation method thereof | |
CN105054040B (en) | A kind of composition of probiotics fermention ginseng and its preparation method and application | |
CN104543679A (en) | Probiotic-containing health food and preparation method thereof | |
CN104970101A (en) | Probiotics troche and preparation method thereof | |
CN105123931A (en) | Probiotic foodstuff and preparation method thereof | |
CN104872674A (en) | Medlar and red date enzyme and preparation method thereof | |
CN104432092A (en) | Probiotic tablet and preparation method thereof | |
CN104543680A (en) | Health food for resisting fatigue and improving gastrointestinal functions and preparation method of health food | |
CN105028646A (en) | Freeze-dried tablets and preparation method thereof | |
CN104473183A (en) | Weight-losing probiotic tablets and preparation method thereof | |
CN105123925A (en) | Freeze-dried foodstuff and preparation method thereof | |
CN105076440A (en) | Freeze-dried fruit and vegetable yoghurt tablet and preparation method thereof | |
CN105028638A (en) | Fruit and vegetable lactic acid bacteria tablet and preparation method thereof | |
CN108785331A (en) | It is a kind of that there is qi-blood tonifying composition and its preparation method and application | |
CN105123949A (en) | Yoghourt tablet containing live bacteria and preparation method thereof | |
CN105104529A (en) | Lactobacillus food and preparation method thereof | |
CN104982526A (en) | Yoghourt slice and preparation method thereof | |
CN105028637A (en) | Fruit puree tablet containing probiotics and preparation method for fruit puree tablet | |
CN105815727A (en) | Honey composition and preparation method thereof | |
CN105123932A (en) | Fruit and vegetable probiotic tablet and preparation method thereof | |
CN105076413A (en) | Fruit and vegetable tablet containing lactic acid bacteria and preparation method of fruit and vegetable tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 312365 Zhejiang Province, Shaoxing city Shangyu District Songxia Town City Station International Plaza building 36 unit room 1-101 Applicant after: ZHEJIANG HONGSHENG TECHNOLOGY TRANSFER SERVICES CO.,LTD. Address before: 312300 Zhejiang Province, Shaoxing city Shangyu District Desheng Baiguan Street building room 2201 West first Applicant before: SHAOXING SHANGYU HONGSHENG TECHNOLOGY TRANSFER SERVICES Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xiaohan Inventor after: Chen Kexiang Inventor before: Shao Suying |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160902 Address after: 510665 Guangdong city of Guangzhou province Tianhe District Tang An Lu 288-298, the first layer and the two layer (A-J 1-14 local axis parts) Guangzhou tanley building materials market A1039-170 Bo Applicant after: GUANGZHOU XIAOSHAN HEALTH TECHNOLOGY CO.,LTD. Address before: 312365 Zhejiang Province, Shaoxing city Shangyu District Songxia Town City Station International Plaza building 36 unit room 1-101 Applicant before: ZHEJIANG HONGSHENG TECHNOLOGY TRANSFER SERVICES CO.,LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191211 Address after: No. 3101, 31 / F, building 4, Zhongyuan Mingdu, No. 30, North University Road, Erqi District, Zhengzhou City, Henan Province Patentee after: Henan Xiaoshan Health Technology Service Co.,Ltd. Address before: 510665 Guangdong city of Guangzhou province Tianhe District Tang An Lu 288-298, the first layer and the two layer (A-J 1-14 local axis parts) Guangzhou tanley building materials market A1039-170 Bo Patentee before: GUANGZHOU XIAOSHAN HEALTH TECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161005 |